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International society of sports nutrition
position stand: caffeine and exercise
performance
Nanci S. Guest1* , Trisha A. VanDusseldorp2, Michael T. Nelson3, Jozo Grgic4, Brad J. Schoenfeld5,
Nathaniel D. M. Jenkins6, Shawn M. Arent7,8, Jose Antonio9, Jeffrey R. Stout10, Eric T. Trexler11,
Abbie E. Smith-Ryan12, Erica R. Goldstein10, Douglas S. Kalman13,14 and Bill I. Campbell15

Abstract
Following critical evaluation of the available literature to date, The International Society of Sports Nutrition (ISSN)
position regarding caffeine intake is as follows:
1. Supplementation with caffeine has been shown to acutely enhance various aspects of exercise performance
in many but not all studies. Small to moderate benefits of caffeine use include, but are not limited to: muscular
endurance, movement velocity and muscular strength, sprinting, jumping, and throwing performance, as well as
a wide range of aerobic and anaerobic sport-specific actions.
2. Aerobic endurance appears to be the form of exercise with the most consistent moderate-to-large benefits
from caffeine use, although the magnitude of its effects differs between individuals.
3. Caffeine has consistently been shown to improve exercise performance when consumed in doses of 3–6 mg/
kg body mass. Minimal effective doses of caffeine currently remain unclear but they may be as low as 2 mg/kg
body mass. Very high doses of caffeine (e.g. 9 mg/kg) are associated with a high incidence of side-effects and
do not seem to be required to elicit an ergogenic effect.
4. The most commonly used timing of caffeine supplementation is 60 min pre-exercise. Optimal timing of
caffeine ingestion likely depends on the source of caffeine. For example, as compared to caffeine capsules,
caffeine chewing gums may require a shorter waiting time from consumption to the start of the exercise
session.
5. Caffeine appears to improve physical performance in both trained and untrained individuals.
6. Inter-individual differences in sport and exercise performance as well as adverse effects on sleep or feelings of
anxiety following caffeine ingestion may be attributed to genetic variation associated with caffeine metabolism,
and physical and psychological response. Other factors such as habitual caffeine intake also may play a role in
between-individual response variation.
7. Caffeine has been shown to be ergogenic for cognitive function, including attention and vigilance, in most
(Continued on next page)
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individuals.
8. Caffeine may improve cognitive and physical performance in some individuals under conditions of sleep
deprivation.
9. The use of caffeine in conjunction with endurance exercise in the heat and at altitude is well supported when
dosages range from 3 to 6 mg/kg and 4–6 mg/kg, respectively.
10. Alternative sources of caffeine such as caffeinated chewing gum, mouth rinses, energy gels and chews have
been shown to improve performance, primarily in aerobic exercise.
11. Energy drinks and pre-workout supplements containing caffeine have been demonstrated to enhance both
anaerobic and aerobic performance.

Introduction
Caffeine is the world’s most widely consumed psychoactive substance and naturally occurs in dozens of plant
species, including coffee, tea and cocoa. Caffeine is
ingested most frequently in the form of a beverage such
as coffee, soft drinks and tea, although the consumption
of many functional beverages, such as energy drinks, has
been on a steady rise in the past two decades [1]. In
Western countries, approximately 90% of adults consume caffeine on a regular basis, with dietary caffeine
consumption of U.S. adult men and women estimated at
approximately 200 mg/day in a 2009–2010 survey [2–4].
In young adults and exercising individuals, there has also
been a rise in the consumption of other caffeinecontaining products, including energy drinks [1, 3], ‘preworkout supplements’, chewing gum, energy gels and
chews, aerosols, and many other novel caffeinated food
products [5]. Caffeine-containing products have a range
of doses per serving, from 1 mg in milk chocolate up to
> 300 mg in some dietary supplements [6].
Caffeine and its effects on health have been a longstanding topic of interest, and caffeine continues to be a
dietary compound of concern in public health, as indicated by extensive investigations [7–10]. At the same
time, caffeine has become ubiquitous in the sporting
world, where there is keen interest in better understanding the impact of caffeine on various types of exercise
performance. Accordingly, caffeine has dominated the
ergogenic aids and sport supplement research domain
over the past several decades [11–13].
Caffeine in sport: a brief history
In the early days (1900s) of modern sport, concoctions
of plant-based stimulants, including caffeine and other
compounds such as cocaine, strychnine, ether, heroin
and nitroglycerin, were developed secretly by trainers,
athletes and coaches, in what appears to be evidence for
early day ergogenic aids designed to provide a competitive advantage [14]. The use of various pharmaceutical
cocktails by endurance athletes continued until heroin
and cocaine became restricted to prescriptions in the

1920s, and further when the International Olympic
Committee (IOC) introduced anti-doping programs in
the late 1960s [15].
Some of the earliest published studies on caffeine
came from two psychologists and colleagues William
Rivers and Harald Webber, at Cambridge University,
who both had an interest in disentangling the psychological and physiological effects of substances like caffeine and alcohol. Rivers and Webber, using themselves
as subjects, investigated the effects of caffeine on muscle
fatigue. The remarkable well-designed studies carried
out from 1906 to 1907 used double-blinded placebocontrolled trials and standardization for diet (i.e. caffeine, alcohol), and were described in a 1907 paper in
the Journal of Physiology [16]. Significant research on
the effects of caffeine on exercise performance with
more subjects, different sports, and exploring variables
such as the effects between trained and untrained individuals, began and continued through the 1940s [14, 17].
However, it was the series of studies investigating the
benefits of caffeine in endurance sports in the Human
Performance Laboratory at Ball State University in the
late 1970s, led by David Costill [18, 19] and others [20],
that sparked a generation of research on the effects of
caffeine in exercise metabolism and sports performance.

Caffeine sources
Along with naturally occurring sources, such as coffee,
tea and cocoa, caffeine is also added to many foods, beverages and novelty products, such as jerky, peanut butter, and candy, in both synthetic (e.g. powder) and
natural (e.g. guarana, kola nut) forms. Synthetic caffeine
is also an ingredient in several over-the-counter and prescription medications, as it is often used in combination
with analgesic and diuretic drugs to amplify their
pharmacological potency [21].
Approximately 96% of caffeine consumption from beverages comes from coffee, soft drinks and tea [22]. Additionally, there are varying levels of caffeine in the beans,
leaves and fruit of more than 60 plants, resulting in great
interest in herbal and other plant-based supplements
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[23–26]. Caffeine-containing energy drink consumption
[27–31] and co-ingestion of caffeine with (e.g. “preworkouts”), or in addition to, other supplements (e.g. caffeine + creatine) is also popular among exercising individuals [32–39]. To date, the preponderance of caffeine and
exercise performance literature has utilized anhydrous caffeine (in a capsule) [40–46] for simpler dose
standardization and placebo creation. There is also a
growing body of literature studying the effects of using alternate delivery methods of caffeine during exercise [5]
such as coffee [18, 47–56], energy drinks, herbal formulas
[57] and ‘pre-workout’ formulas, among others. A review
of alternate caffeine forms may be found in the Alternative
caffeine sources section and Tables 4, 5, 6, 7 and 8.

Caffeine legality in sport
Anti-doping rules apply to most sports, especially in
those where athletes are competing at national and
international levels. The IOC continues to recognize that
caffeine is frequently used by athletes because of its reported performance-enhancing or ergogenic effects
[109]. Caffeine was added to the list of banned substances by the IOC in 1984 and the World Anti-Doping
Agency (WADA) in 2000. A doping offense was defined
as having urinary caffeine concentrations exceeding a
cut-off of 15 μg/ml. In 1985, the threshold was reduced
to 12 μg/ml [110]. The cut-off value was chosen to exclude typical amounts ingested as part of common dietary or social coffee drinking patterns, and to
differentiate it from what was considered to be an aberrant use of caffeine for the purpose of sports performance enhancement [111].
The IOC and WADA removed the classification of
caffeine as a “controlled” substance in 2004, leading to a
renewed interest in the use of caffeine by athletes. However, caffeine is still monitored by WADA, and athletes
are encouraged to maintain a urine caffeine concentration below the limit of 12 μg/ml urine which corresponds to 10 mg/kg body mass orally ingested over
several hours, and which is more than triple the intake
reported to enhance performance [112, 113]. Interestingly, caffeine is also categorized as a banned substance
by the National Collegiate Athletic Association (NCAA),
if urinary caffeine concentration exceeds 15 μg/ml,
which is greater than the “monitored substance” level set
for WADA [114], and also well above amounts that are
deemed ergogenic.
A comparison of caffeine concentrations obtained during in-competition doping control from athletes in several sports federations pre− 2004 versus post-2004,
indicated that average caffeine concentrations decreased
in 2004 after removal from the prohibited substance list
[110]. Reports on over 20,000 urine samples collected
and analyzed after official national and international
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competitions between 2004 and 2008, and again in 2015
using 7500 urine samples found overall prevalence of
caffeine use across various sports to be about 74% in the
2004 to 2008 time period and roughly 76% in 2015. The
highest use of caffeine was among endurance athletes in
both studies [115, 116]. Urinary caffeine concentration
significantly increased from 2004 to 2015 in athletics,
aquatics, rowing, boxing, judo, football, and weightlifting; however, the sports with the highest urine caffeine
concentration in 2015 were cycling, athletics, and rowing
[116].

Caffeine pharmacokinetics
Caffeine or 1,3,7-trimethylxanthine, is an odorless white
powder that is soluble in both water and lipids and has a
bitter taste. It is rapidly absorbed from the gastrointestinal tract, mainly from the small intestine but also in
the stomach [117]. In saliva, caffeine concentration
reaches 65–85% of plasma levels, and is often used to
non-invasively monitor compliance for ingestion or abstinence of caffeine [118]. Caffeine is effectively distributed throughout the body by virtue of being sufficiently
hydrophobic to allow easy passage through most, if not
all biological membranes, including the blood-brain barrier [119]. When caffeine is consumed it appears in the
blood within minutes, with peak caffeine plasma concentrations after oral administration reported to occur at
times (Tmax) ranging from 30 to 120 min [43, 120–122].
The absolute bioavailability of caffeine is very high and
reaches near 100% as seen in studies reporting areas
under the plasma concentration-time curves (AUC)
[120]. Once caffeine is absorbed, there appears to be no
hepatic first-pass effect (i.e., the liver does not appear to
remove caffeine as it passes from the gut to the general
circulation), as evidenced by similar plasma concentration curves when administered by either oral or intravenous routes [123]. Caffeine absorption from food and
beverages does not seem to be dependent on age, gender, genetics or disease, or the consumption of drugs, alcohol or nicotine. However, the rates of caffeine
metabolism and breakdown appear to differ between individuals through both environmental and genetic influences [3, 124, 125].
Over 95% of caffeine is metabolized in the liver by the
Cytochrome P450 1A2 (CYP1A2) enzyme, a member of
the cytochrome P450 mixed-function oxidase system,
which metabolizes and detoxifies xenobiotics in the body
[126]. CYP1A2 catalyzes the demethylation of caffeine
into the primary metabolites paraxanthine (1,7-dimethylxanthine), theobromine (3,7-dimethylxanthine) and
theophylline (1,3-dimethylxanthine), which account for
approximately 84, 12, and 4%, of total caffeine elimination, respectively [127, 128]. These three caffeine metabolites undergo further demethylations and oxidation
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to urates in the liver with about 3–5% remaining in caffeine form when excreted in the urine [129, 130]. While
the average half-life (t1/2) of caffeine is generally reported
to be between 4 and 6 h, it varies between individuals
and even may range from 1.5 to 10 h in adults [120].
The wide range of variability in caffeine metabolism is
due to several factors. The rate of caffeine metabolism
may be inhibited or decreased with pregnancy or use of
hormonal contraceptives [125], increased or induced by
heavy caffeine use [131] cigarette smoking [132] or
modified in either direction by certain dietary factors
[133] and/or variation in the CYP1A2 gene, which will
be discussed later [125, 132–134].
Several studies have also shown that the form of caffeine or its vehicle for entry into the body can modify
the pharmacokinetics [58, 81, 119, 122]. One small trial
(n = 3) evaluated Tmax for a variety of beverages that all
included 160 mg of caffeine but in different volumes of
solution, and reported that Tmax occurs at 0.5, 0.5, and
2 h for coffee, tea and cola, respectively [135]. In another
study involving seven participants, caffeine plasma concentrations peaked rapidly at 30 min for capsule form,
whereas caffeine absorption from cola and chocolate was
delayed and produced lower plasma concentrations that
peaked at roughly 90–120 min after consumption. This
study also did not control for volume of administered
solution (capsules and chocolate ingested with 360 ml
water and 800 ml cola) [122]. Liguori et al. [136] evaluated a 400 mg dose of caffeine in 13 subjects and reported salivary caffeine Tmax values of 42, 39 and 67
min, for coffee, sugar-free cola and caffeine capsules, respectively. However, fluid volume was again not standardized (coffee – 12 oz., sugar-free cola – 24 oz.,
capsules – volume of administered fluid not reported).
The impact of temperature or rate of ingestion of caffeine has also been investigated, amidst concerns that
cold energy drinks might pose a danger when chugged
quickly, compared to sipping hot coffee. One study [121]
compared five conditions that included: slow ingestion
(20 min) of hot coffee, and fast (2-min) or slow (20-min)
ingestion for both cold coffee and energy drinks. Similar
to other caffeine pharmacokinetic studies [122, 135],
White et al. [121] reported that although the rate of consumption, temperature, and source (coffee vs. energy
drink) may be associated with slight differences in pharmacokinetic activity, these differences are small.
Chewing gum formulations appear to alter pharmacokinetics, as much of the caffeine released from the gum
through mastication can be absorbed via the buccal cavity, which is considered faster due to its extensive
vascularization, especially for low molecular weight
hydrophobic agents [137]. Kamimori et al. [58] compared the rate of absorption and relative caffeine bioavailability from chewing gum compared to a capsule
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form of caffeine. Although caffeine administered in the
chewing gum formulation was absorbed at a significantly
faster rate, the overall bioavailability was comparable to
the capsuled 100 and 200 mg caffeine dose groups.
These pharmacokinetic findings are useful for military
and sport purposes, where there is a requirement for
rapid and maintained stimulation over specific periods
of time. Chewing gum may also be advantageous due to
reduced digestive requirements, where absorption of caffeine in other forms (capsule, coffee etc.) may be hindered by diminished splanchnic blood flow during
moderate to intense exercise. Finally, there is a growing
prevalence of caffeinated nasal and mouth aerosols administered directly in the mouth, under the tongue or
inspired may affect the brain more quickly through several proposed mechanisms [5], although there are only a
few studies to date to support this claim. The administration of caffeine via aerosol into the oral cavity appears
to produce a caffeine pharmacokinetic profile comparable to the administration of a caffeinated beverage [81].
Nasal and mouth aerosols will be discussed further in
another section.

Mechanism of Action (MOA)
Although the action of caffeine on the central nervous
system (CNS) has been widely accepted as the primary
mechanism by which caffeine alters performance, several
mechanisms have been proposed to explain the ergogenic effects of caffeine, including increased myofibrillar
calcium availability [138, 139], optimized exercise metabolism and substrate availability [45], as well as stimulation of the CNS [140–142]. One of the earlier
proposed mechanisms associated with the ergogenic effects of caffeine stemmed from the observed adrenaline
(epinephrine)-induced enhanced free-fatty acid (FFA)
oxidation after caffeine ingestion and consequent glycogen sparing, resulting in improved endurance performance [18, 45, 143]. However, this substrate-availability
hypothesis was challenged and eventually dismissed,
where after several performance studies it became clear
that the increased levels of FFAs appeared to be higher
earlier in exercise when increased demand for fuel via
fat oxidation would be expected [141, 144, 145]. Furthermore, this mechanism could not explain the ergogenic
effects of caffeine in short duration, high-intensity exercise in which glycogen levels are not a limiting factor.
Importantly, several studies employing a variety of exercise modalities and intensities failed to show a decrease
in respiratory exchange ratio (RER) and/or changes in
serum FFAs, which would be indicative of enhanced fat
metabolism during exercise when only water was
ingested [144, 146–148]. Ingestion of lower doses of caffeine (1–3 mg/kg of body mass), which do not result in
significant physiological responses (i.e. RER, changes in
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blood lactate, glucose), also appear to deliver measurable
ergogenic effects, offering strong support for the CNS as
the origin of reported improvements [43, 149, 150]. As
such, focus has shifted to the action of caffeine during
exercise within the central and peripheral nervous systems, which could alter the rate of perceived exertion
(RPE) [151–154], muscle pain [151, 155–157], and possibly the ability of skeletal muscle to generate force
[151].
Caffeine does appear to have some direct effects on
muscle which may contribute to its ergogenicity. The
most likely pathway that caffeine may benefit muscle
contraction is through calcium ion (Ca2+) mobilization,
which facilitates force production by each motor unit
[138, 139, 150, 158]. Fatigue caused by the gradual reduction of Ca2+ release may be attenuated after caffeine
ingestion [139, 159]. Similarly, caffeine may work, in
part, in the periphery through increased sodium/potassium (Na+/K+) pump activity to potentially enhance
excitation-contraction coupling necessary for muscle
contraction [160]. Caffeine appears to employ its effects
at various locations in the body, but the most robust evidence suggests that the main target is the CNS, which is
now widely accepted as the primary mechanism by
which caffeine alters mental and physical performance
[141]. Caffeine is believed to exert its effects on the CNS
via the antagonism of adenosine receptors, leading to increases in neurotransmitter release, motor unit firing
rates, and pain suppression [151, 155–157, 161]. There
are four distinct adenosine receptors, A1, A2A, A2B and
A3, that have been cloned and characterized in several
species [162]. Of these subtypes, A1 and A2A, which are
highly concentrated in the brain, appear to be the main
targets of caffeine [163]. Adenosine is involved in numerous processes and pathways, and plays a crucial role
as a homeostatic regulator and neuromodulator in the
nervous system [164]. The major known effects of adenosine are to decrease the concentration of many CNS
neurotransmitters, including serotonin, dopamine,
acetylcholine, norepinephrine and glutamate [163–165].
Caffeine, which has a similar molecular structure to adenosine, binds to adenosine receptors after ingestion and
therefore increases the concentration of these neurotransmitters [163, 165]. This results in positive effects on
mood, vigilance, focus, and alertness in most, but not all,
individuals [166, 167].
Researchers have also characterized aspects of adenosine A2A receptor function related to cognitive processes
[168] and motivation [169, 170]. In particular, several
studies have focused on the functional significance of
adenosine A2A receptors and the interactions between
adenosine and dopamine receptors, in relation to aspects
of behavioral activation and effort-related processes
[168–171]. The serotonin receptor 2A (5-HT2A) has
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also been shown to modulate dopamine release, through
mechanisms involving regulation of either dopamine
synthesis or dopaminergic neuron firing rate [172, 173].
Alterations in 5-HTR2A receptors may therefore affect
dopamine release and upregulation of dopamine receptors [174, 175]. A possible mechanism for caffeine’s
ergogenicity may involve variability in 5-HTR2A receptor activity, which may modulate dopamine release and
consequently impact alertness, pain and motivation and
effort [141]. 5-HTR2A receptors are encoded by the
HTR2A gene, which serves as a primary target for serotonin signaling [176], and variations in the gene have
been shown to affect 5-HTR2A receptor activity [177,
178]. This may therefore modulate dopamine activity,
which may help to elucidate some of the relationships
among neurotransmitters, genetic variation and caffeine
response, and the subsequent impact on exercise
performance.
Muscle pain has been shown to negatively affect motor
unit recruitment and skeletal muscle force generation
proportional to the subjective scores for pain intensity
[179, 180]. In one study, progressively increased muscle
pain intensity caused a gradual decrease in motor firing
rates [179]. However, this decrease was not associated
with a change in motor unit membrane properties demonstrating a central inhibitory motor control mechanism
with effects correlated to nociceptive activity [179].
Other studies also indicate that muscle force inhibition
by muscle pain is centrally mediated [181]. Accordingly,
caffeine-mediated CNS mechanisms, such as dopamine
release [182], are likely imputable for pain mitigation
during high-intensity exercise [155–157, 181, 183–186].
Although there appears to be strong evidence supporting
the analgesic effects of caffeine during intense exercise,
others have found no effect [185, 187].
The attenuation of pain during exercise as a result of
caffeine supplementation may also result in a decrease
in the RPE during exercise. Two studies [183, 184] have
reported that improvements in performance were accompanied by a decrease in pain perception as well as a
decrease in RPE under caffeine conditions, but it is unclear which factor may have contributed to the ergogenic effect. Acute caffeine ingestion has been shown to
alter RPE, where effort may be greater under caffeine
conditions, yet it is not perceived as such [12, 152–154].
A meta-analysis [12] identified 21 studies using mostly
healthy male subjects (74%) between the ages of 20 and
35 years and showed a 5.6% reduction in RPE during exercise following caffeine ingestion. An average improvement in performance of 11% was reported across all
exercise modalities. This meta-analysis established that
reductions in RPE explain up to 29% of the variance in
the improvement in exercise performance [12]. Others
have not found changes in RPE with caffeine use [187].
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A more recent study by Green et al. [188] also showed
that when subjects were instructed to cycle at specific
RPE (effort) levels under caffeine conditions, the higher
perceived intensity did not necessarily result in greater
work and improved performance in all subjects equally.
The authors noted that individual responses to caffeine
might explain their unexpected findings.
In the last decade, our understanding of CNS fatigue
has improved. Historically, it is well- documented that
“psychological factors” can affect exercise performance
and that dysfunction at any step in the continuum from
the brain to the peripheral contractile machinery will result in muscular fatigue [189, 190]. The role of the CNS
and its ‘motor drive’ effect was nicely shown by Davis
et al. [191] who examined the effect of caffeine injected
directly into the brains of rats on their ability to run to
exhaustion on a treadmill. In this controlled study, rats
were injected with either vehicle (placebo), caffeine, 5′N-Ethylcarboxamido adenosine (NECA), an adenosine
receptor agonist, or caffeine NECA together. Rats ran
80 min in the placebo trial, 120 min in the caffeine trial
and only 25 min with NECA. When caffeine and NECA
were given together, the effects appeared to cancel each
other out, and run time was similar to placebo. When
the study was repeated with peripheral intraperitoneal
(body cavity) injections instead of brain injections, there
was no effect on run performance. The authors concluded that caffeine increased running time by delaying
fatigue through CNS effects, in part by blocking adenosine receptors [191]. Caffeine also appears to enhance
cognitive performance more in fatigued than well-rested
subjects [192–194]. This phenomenon is also apparent
in exercise performance [195] both in the field [196] and
in the lab [60, 63, 149].
The placebo effect

The placebo effect is a beneficial outcome that cannot
be attributed to a treatment or intervention but is
brought about by the belief that one has received a positive intervention. For example, an individual may ingest
a capsule with sugar or flour (a small amount of nonactive ingredient) but believes that he/she ingested caffeine and experiences improvements in performance because of this belief [197]. The nocebo effect is directly
opposite to this in that a negative outcome occurs following the administration of an intervention or lack of
an intervention (e.g. knowingly ingesting a placebo)
[198]. For example, the nocebo may be a substance without medical effects, but which worsens the health status
of the person taking it by the negative beliefs and expectations of the patient. Similarly, the nocebo may be a
‘caffeine placebo’, where an individual’s performance is
worse based on the belief that they did not ingest
caffeine.
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Several studies have provided evidence for placebo effects associated with caffeine ingestion [199–201] or
other “beneficial” interventions [202] during exercise. An
example of this was reported in a study [200] where
well-trained cyclists exhibited a linear dose–response relationship in experimental trials from baseline to a moderate (4.5 mg/kg) and high dose (9 mg/kg) of caffeine
respectively. Athletes improved as the perceived caffeine
doses increased; however, a placebo was used in all interventions. Similarly, Saunders et al. [201] found that
correct identification of caffeine appears to improve cycling performance to a greater extent than the overall effect of caffeine, where participants who correctly
identified placebo showed possible harmful effects on
performance. Therefore, readers are encouraged to consider whether studies that have explored the effects of
caffeine on exercise have examined and reported the efficacy of the blinding of the participants.

Caffeine and endurance exercise
Less than a 1% change in average speed is enough to
affect medal rankings in intense Olympic endurance
events lasting ~ 45 s to 8 min [203]. In other events, such
as the men’s individual road race, the difference between
the top three medalists was < 0.01% [204]. At the highest
level of sports, competitors will be near their genetic potential, will have trained intensively, followed prudent recovery protocols, and will have exploited all strategies to
improve their performance—the use of an ergogenic aid,
when legal, safe and effective, is an alluring opportunity.
Caffeine has consistently been shown to improve endurance by 2–4% across dozens of studies using doses of
3–6 mg/kg body mass [13, 195, 205–207]. Accordingly,
caffeine is one of the most prominent ergogenic aids and
is used by athletes and active individuals in a wide variety of sports and activities involving aerobic endurance.
Caffeine has been shown to benefit several endurancetype sports including cycling [60, 206, 208], running [91,
209, 210] cross-country skiing [211] and swimming
[212].
Much of the caffeine-exercise body of literature has focused on endurance-type exercise, as this is the area in
which caffeine supplementation appears to be more
commonly used and likely beneficial in most, but not all,
athletes [11–13]. For example, the caffeine concentration
in over twenty thousand urine samples obtained for doping control from 2004 to 2008 was measured after official national and international competitions [110, 115].
The investigations concluded that roughly 74% of elite
athletes used caffeine as an ergogenic aid prior to or
during a sporting event, where endurance sports are the
disciplines showing the highest urine caffeine excretion
(and therefore prevalence) after competition [110, 115].
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A recent meta-analysis reporting on 56 endurance time
trials in athletes (79% cycling), found the percent difference between the caffeine and placebo group ranged from
− 3.0 to 15.9% [195]. This wide range in performance outcomes highlights the substantial inter-individual variability
in the magnitude of caffeine’s effects as reported. These
inter-individual differences might be due to the methodological differences between the studies, habitual caffeine
intake of the participants, and/or partly due to variation in
genes that are associated with caffeine metabolism and
caffeine response [213].
A recent systematic review was carried out on randomised placebo-controlled studies investigating the effects
of caffeine on endurance performance and a metaanalysis was conducted to determine the ergogenic effect
of caffeine on endurance time-trial performance [205].
Forty-six studies met the inclusion criteria and were included in the meta-analysis. This meta-analysis found
that caffeine has a small but significant effect on endurance performance when taken in moderate doses (3–6
mg/kg) as well as an overall improvement following caffeine compared to placebo in mean power output of
2.9 ± 2.2% and a small effect size of 0.22 ± 0.15. Timetrial completion time showed improvements of 2.3 ±
2.6% with a small effect size of 0.28 ± 0.12. However,
there was some variability in outcomes with responses
to caffeine ingestion, with two studies reporting slower
time-trial performance, and five studies reporting lower
mean power output during the time–trial [205].
In summary, caffeine has been consistently shown to
be effective as an ergogenic aid when taken in moderate
doses (3–6 mg/kg), during endurance-type exercise and
sport. Dozens of endurance studies are highlighted
through this review is various sections, showing consistent yet wide-ranging magnitudes of benefit for endurance performance under caffeine conditions.

Caffeine and muscular endurance, strength and
power
Strength and power development through resistance exercise is a significant component of conditioning programs for both fitness and competitive sport. The most
frequently consumed dose of caffeine in studies using
strength tasks with trained or untrained individuals usually ranges from 3 to 6 mg/kg body mass (with 2 mg to
11 mg representing the entire range), ingested in the
form of pills or capsules 30 to 90 min before exercise. In
resistance exercise, strength is most commonly assessed
using 1 repetition maximum (1RM) [214], or different
isometric and isokinetic strength tests [215]. Muscular
endurance assesses the muscle’s ability to resist fatigue
and is an important quality in many athletic endeavors
(e.g., swimming, rowing). Muscular endurance may be
tested with repetitions of squats, maximal push-ups,
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bench press exercises (load corresponding to 60–70% of
1RM) to momentary muscular failure, or by isometric
exercises such as the plank or static squat [216, 217].
Although several studies exploring the effects of caffeine on strength performance have been published since
the 2010 ISSN caffeine position stand [40], some uncertainty surrounding the benefits of caffeine in activities
involving muscular endurance, strength and power
remains.
Caffeine was shown to be ergogenic for muscular endurance in two meta-analyses reporting effect sizes ranging from 0.28 to 0.38 (percent change range: 6 to 7%)
[158, 218]. However, others have shown that it enhances
strength but not muscular endurance [219, 220], and
when studies have examined multiple strength-muscular
endurance tasks, there were benefits across the board
[67, 221], none at all [98, 222], or even impairments in
muscular endurance with caffeine use [222, 223]. Ingesting caffeine prior to a muscular endurance task is likely
to delay muscular fatigue, but these effects are not consistent among all studies.
Three meta-analyses explored the acute effects of caffeine on strength, and all reported ergogenic effects
[158, 224, 225]. However, the effects in these metaanalyses were small, ranging from 0.16 to 0.20 (percent
change: 2 to 7%). Such small improvements in muscular
strength likely have the greatest practical meaningfulness
for athletes competing in strength-based sports, such as
powerlifting and weightlifting (athletes which already
seem to be among the highest users of caffeine [110]).
Power output is often measured during a single-bout
sprinting task using the Wingate test, which generally
consists of ‘all-out’ cycling for 30 s performed at specific
external loads (e.g., 7.5% of body mass). Power output is
also assessed during different protocols of intermittentsprinting and repeated-sprints often with the Wingate
cycling test as well as assessments during running [226]
or swimming repeated sprints [212].
The data for repeated sprint and power performance
using Wingate data has been mixed. In an older study,
10 male team-sport athletes performed 18, 4-s sprints
with 2-min active recovery [227]. Here, caffeine ingestion (6 mg/kg) enhanced mean power output and sprint
work by 7 and 8.5%, respectively [227]. A more recent
study examining the effects of acute caffeine ingestion
on upper and lower body Wingate performance in 22
males did not report significant findings when measuring lower body mean and peak power using the Wingate
test [228]. An older study by Greer et al. [229] also failed
to report caffeine benefits on power output during a 30s high-intensity cycling bout using the Wingate test.
One meta-analysis reported that caffeine ingestion enhances mean and peak power during the Wingate test
[230], although the effect sizes of 0.18 (+ 3%) and 0.27
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(+ 4%), respectively are modest. In contrast, another
meta-analysis that examined the effects of caffeine on
muscle power as assessed with the Wingate test for three
of the studies, and repeated sprints for a maximum of
10-s for the fourth, did not report benefits from ingestion of caffeine [231]. An average caffeine dose of 6.5
mg/kg of body mass was used across the four studies
with no improvements in muscle power under caffeine
conditions (effect size = 0.17, p = 0.36) compared to placebo trials, although the data collected spanned only 5
years [231]. A study by Lee et al. [232] reported that caffeine ingestion enhanced sprint performance involving a
90-s rest interval (i.e., intermittent-sprinting) but did not
benefit repeated-sprints with a 20-s rest interval. This
might suggest that the rest interval between sprints may
modulate the ergogenic effects of caffeine. Indeed, a recent meta-analysis that focused on the effects of caffeine
on repeated-sprint performance reported that total work,
best sprint, and last sprint performance was not affected
by caffeine ingestion [226].
Several studies have also shown substantial variability
in outcomes. For example, one study [63] found that
only 13 of 20 cyclists improved their performance with
~ 3–4 mg/kg of caffeine, while the remaining participants either worsened or did not alter their performance.
Similarly, Woolf et al. [233] found that 5 mg/kg of caffeine improved overall peak power performance on the
Wingate Test in 18 elite or professional athletes. However, 4 (28%) of the participants did not improve their
performance with caffeine. Average power, minimum
power, and power drop were not significantly different
between treatments, but 72% of the participants obtained a greater peak power during the caffeine trial than
during the placebo trial. There was also no overall improvement in average power or fatigue index, despite 13
(72%), and 9 (50%) of the participants, respectively, improving their performance. In summary, caffeine ingestion may be beneficial to enhance single and
intermittent-sprint performance, while caffeine’s effects
on repeated-sprint performance are inconsistent and require further research to draw stronger conclusions on
the topic.
Ballistic movements (such as throws and jumps) are
characterized by high motor unit firing rates, brief contraction times, and high rates of force development
[234]. Many studies have explored the effects of caffeine
on jumping performance [225, 235]. The body of evidence has indicated that caffeine supplementation increases vertical jump height during single and repeated
jumps; however, the magnitude of these effects is rather
modest, with effect sizes ranging from 0.17 to 0.22 (2 to
4%) [225, 235]. Besides jumping, several studies have explored the effects of caffeine on throwing performance.
These studies reported that: (a) caffeine ingestion

(2021) 18:1

Page 8 of 37

enhanced maximal shot put throwing distance in a
group of 9 nine inter-collegiate track and field athletes
[65]; and (b) caffeine ingestion at a dose of 6 mg/kg of
body mass administered 60 min pre-exercise increased
maximal medicine ball throwing distance [236]. Overall,
the current body of evidence indicates that caffeine supplementation may be useful for acute improvements in
ballistic exercise performance in the form of jumps and
throws. However, more research is needed to explore
the effects of caffeine on different throwing exercise
tests, as this has been investigated only in a few studies.
Generally, the primary sports-related goal of strength
and power-oriented resistance training programs is to
move the force-velocity curve to the right, indicating an
ability of the athlete to lift greater loads at higher velocities [237]. Several studies have explored the effects of
caffeine on movement velocity and power in resistance
exercise using measurement tools such as linear position
transducers [238]. These studies generally report that
caffeine ingestion provides ergogenic effects of moderate
to large magnitudes, with similar effects noted for both
mean and peak velocity, and in upper and lower-body
exercises [67, 221, 239]. Even though this area merits
further research to fill gaps in the literature, the initial
evidence supports caffeine as an effective ergogenic aid
for enhancing velocity and power in resistance exercise.

Caffeine and sport-specific performance
Even though caffeine ingestion may enhance performance in the laboratory, there has been a paucity of evidence to support that these improvements transfer
directly to sport-specific performance. To address this
issue, several studies have also explored the effects of
caffeine on sport-specific exercise tasks using sport
simulation matches. Many studies conducted among
athletes competing in team and individual sports, report
that caffeine may enhance performance in a variety of
sport tasks. However, there are also several studies that
report no effects as outlined below:
 Basketball – increased jump height, but only in

those with the AA version of the CYP1A2 gene
[240], increased number of free throws attempted
and free throws made, increased number of total
and offensive rebounds [241], but did not improve
sprint time [240], nor dribbling speed [242]
 Soccer – increased total distance covered during the
game, increased passing accuracy, and jumping
height [94, 243, 244], but the consumption of a
caffeinated energy drink did not enhance
performance in the “T test” in female soccer players
[245], nor during match play in young football
players [246]
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 Volleyball – increased number of successful












volleyball actions and decreased the number of
imprecise actions [247, 248], although caffeine did
not improve physical performance in multiple sportspecific tests in professional females [249], nor performance in volleyball competition [250]
Football - did not improve performance for
anaerobic exercise tests used at the NFL Combine
[251]
Rugby – increased the number of body impacts,
running pace, and muscle power during jumping
[252, 253], but did not impact agility [254]
Field hockey – increased high-intensity running and
sprinting [255], and may offset decrements in skilled
performance associated with fatigue [256]
Ice-hockey - has limited impact on sport-specific
skill performance and RPE, but may enhance physicality during scrimmage [257]
Combat sports – increased number of offensive
actions and increased the number of throws [258]
Cross-country skiing – reduced time to complete a
set distance [259] and improved time to task failure
[211]

In summary, although reviews of the literature show
that caffeine ingestion is, on average, ergogenic for a
wide range of sport-specific tasks, its use might not be
appropriate for every athlete. Specifically, the use of caffeine needs to be balanced with the associated sideeffects and therefore experimentation is required in
order to determine the individual response before assessing whether the benefits outweigh the costs for the athlete. Athletes should gauge their physical response to
caffeine during sport practice and competition in
addition to monitoring mood state and potentially disrupted sleep patterns.

Interindividual variation in response to caffeine
There is a lack of research examining potential interindividual differences in strength or anaerobic power-type
exercise, but this is not the case for endurance exercise.
In the myriad of studies examining caffeine on endurance performance, the benefits of caffeine do not appear
to be influenced by sex, age, VO2 max, type of sport, or
the (equivalent) dose of caffeine [13, 195, 260]. Nevertheless, there appears to be substantial interindividual
variability in response to caffeine under exercise conditions, which may be attributed to several factors outlined
below.
Genetics

Genetic variants affect the way we absorb, metabolize, and
utilize and excrete nutrients, and gene-diet interactions
that affect metabolic pathways relevant to health and
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performance are now widely recognized [261]. In the field
of nutrigenomics, caffeine is the most widely researched
compound with several randomized controlled trials investigating the modifying effects of genetic variation on
exercise performance [75, 208, 262, 263].
Numerous studies have investigated the effect of supplemental caffeine on exercise performance, but there is
considerable inter-individual variability in the magnitude
of these effects [11, 13, 44] or in the lack of an effect
[264, 265], when compared to placebo. Due to infrequent reporting of individual data it is difficult to determine the extent to which variation in responses may be
occurring. The performance of some individuals is often
in stark contrast to the average findings reported, which
may conclude beneficial, detrimental, or no effect of caffeine on performance. For example, Roelands et al. [265]
reported no ergogenic effect of caffeine in a study involving trained male cyclists. The authors concluded
that inter-individual differences in response to caffeine
might be responsible for the lack of overall performance
improvement, as 50% of subjects improved while 50%
worsened, in the caffeine compared to the placebo trial.
These inter-individual differences appear to be partly
due to variations in genes such as CYP1A2 and possibly
ADORA2A, which are associated with caffeine metabolism, sensitivity and response [213]. Over 95% of caffeine
is metabolized by the CYP1A2 enzyme, which is
encoded by the CYP1A2 gene and is involved in the demethylation of caffeine into the primary metabolites
paraxanthine, theophylline and theobromine [127]. The
-163A > C (rs762551) single nucleotide polymorphism
(SNP) has been shown to alter CYP1A2 enzyme inducibility and activity [132, 134], and has been used to
categorize individuals as ‘fast’ or ‘slow’ metabolizers of
caffeine. In the general population, individuals with the
AC or CC genotype (slow metabolizers) have an elevated
risk of myocardial infarction [266], hypertension and elevated blood pressure [267, 268], and pre-diabetes [269],
with increasing caffeinated coffee consumption, whereas
those with the AA genotype show no such risk. Additionally, regular physical activity appears to attenuate
the increase in blood pressure induced by caffeine ingestion, but only in individuals with the AA genotype [268].
The largest caffeine, genetics and exercise study to
date [208] examined the effects of caffeine and CYP1A2
genotype on 10-km cycling time trial performance in
competitive male athletes (both endurance and power
sports) after ingestion of placebo, and caffeine doses of
2 mg (low dose) or 4 mg (moderate dose) per kg body
mass. There was a 3% improvement in cycling time with
the moderate dose in all subjects, which is consistent
with previous studies using similar doses [13, 206]. However, there was a significant caffeine-gene interaction;
improvements in performance were seen at both caffeine
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doses, but only in those with the AA genotype who are
‘fast metabolizers’ of caffeine. In that group, a 6.8% improvement in cycling time was observed at 4 mg/kg,
which is greater than the 2–4% mean improvement seen
in several other studies using cycling time trials and
similar doses [13, 201, 206, 207, 270–272]. Among those
with the CC genotype (i.e., “slow metabolizers”), 4 mg/kg
caffeine impaired performance by 13.7%, whereas no difference was observed between the placebo and 2 mg/kg
caffeine trials. In those with the AC genotype there was
no effect of either dose [208]. The findings are consistent with a previous study [263] that observed a caffeinegene interaction indicating improved time trial cycling
performance following caffeine consumption only in
those with the AA genotype.
In contrast, previous studies either did not observe any
impact of the CYP1A2 gene in caffeine-exercise studies
[273, 274], or reported benefits only in slow metabolizers
[75]. There are several reasons that may explain discrepancies in study outcomes. These include smaller samples
sizes with few and/or no subjects in one genotype [75,
273, 274], as well as shorter distances or different types
of performance test (power versus endurance) [75] compared to the aforementioned trials, which reported improved endurance after caffeine ingestion in those with
the CYP1A2 AA genotype [208, 263]. The effects of
genotype on performance might be the most prominent
during training or competition of longer duration or an
accumulation of fatigue (aerobic or muscular endurance)
[149], where caffeine appears to provide its greatest benefits, and where the adverse effects to slow metabolizers
are more likely to manifest [195, 260]. Indeed, in a study
of performance in elite basketball players [240], only in
those with the AA genotype caffeine improved repeated
jumps which requires maintaining velocity at take-off repeatedly as an athlete fatigues throughout a game (muscular endurance) - even though there was no caffeinegenotype interaction effect for this outcome. However,
caffeine similarly improved performance in those with
the both AA and C-genotypes during a simulated basketball game [240]. In a cross-over design of 30
resistance-trained men, caffeine ingestion resulted in a
higher number of repetitions in repeated sets of three
different exercises, and for total repetitions in all resistance exercises combined, which resulted in a greater volume of work compared to placebo conditions, but only
in those with the CYP1A2 AA genotype [262]. Although
more research is warranted, there is a growing body of
evidence to support the role of CYP1A2 in modifying
the effects of caffeine ingestion on aerobic or muscular
endurance-type exercise, which helps to determine
which athletes are most likely to benefit from caffeine.
The ADORA2A gene is another genetic modifier of the
effects of caffeine on performance. The adenosine A2A
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receptor, encoded by the ADORA2A gene, has been
shown to regulate myocardial oxygen demand and increase coronary circulation by vasodilation [275, 276].
The A2A receptor is also expressed in the brain, where it
has significant roles in the regulation of glutamate and
dopamine release, with associated effects on insomnia
and pain [277, 278]. The antagonism of adenosine receptors after caffeine ingestion is modified by the
ADORA2A gene, which may allow greater improvements
in dopamine transmission and lead to norepinephrine
and epinephrine release due to increased neuronal firing
[168] in some genotypes versus others. Dopamine has
been associated with motivation and effort in exercising
individuals, and this may be the mechanism by which
differences in response to caffeine are manifested [141,
168, 169].
Currently, only one small pilot study has examined the
effect of the ADORA2A gene (rs5751876) on the ergogenic effects of caffeine under exercise conditions [279].
Twelve female subjects underwent a double-blinded,
crossover trial comprising two 10-min cycling time trials
following caffeine ingestion or placebo. Caffeine benefitted all six subjects with the TT genotype, but only one
of the six C allele carriers. Further studies are needed to
confirm these preliminary findings and should include a
large enough sample to distinguish any effects between
the different C allele carriers (i.e. CT vs. CC genotypes)
and potential effects related to sex.
The ADORA2A rs5751876 genotype has also been implicated, by both objective and subjective measures, in
various parameters of sleep quality after caffeine ingestion in several studies [280–283]. Adenosine promotes
sleep by binding to its receptors in the brain, mainly A1
and A2A receptors, and caffeine exerts an antagonist effect, blocking the receptor and reversing the effects of
adenosine and promoting wakefulness [280]. This action,
as well as the potency of caffeine to restore performance
(cognitive or physical) in ecological situations, such as
highway-driving during the night [284], supports the notion that the adenosine neuromodulator/receptor system
is significantly involved in sleep–wake regulation. This
action of caffeine may also serve athletes well under conditions of jetlag, and irregular or early training or competition schedules. Psychomotor speed relies on the
ability to respond, rapidly and reliably, to randomly occurring stimuli which is a critical component of, and
characteristic of, most sports [285]. Genetic variation in
ADORA2A has been shown to be a relevant determinant
of psychomotor vigilance in the rested and sleepdeprived state and modulates individual responses to
caffeine after sleep deprivation [282]. Those with the CC
genotype of ADORA2A rs5751876 consistently performed on a higher level on the sustained vigilant attention task than T-allele -carriers; however, this was tested
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in ADORA2A haplotypes that included combinations of
8 SNPs. This work provides the basis for future genetic
studies of sleep using individual ADORA2A SNPs.
As mentioned, the ADORA2A genotype has also been
implicated in sleep quality and increases in sleep disturbance [283]. Consistent with the “adenosine hypothesis” of sleep where the accumulation of adenosine in
the brain increases sleep propensity, caffeine prolongs
time to fall asleep, decreases the deep stages of nonrapid-eye movement (nonREM) sleep, reduces sleep efficiency, and alters the waking and sleep electroencephalogram (EEG) frequencies, which reliably reflect the
need for sleep [286–288]. Increased beta activity in nonREM sleep may characterize individuals with insomnia
when compared with healthy good sleepers [289]. A
functional relationship between the ADORA2A genotype
and the effect of caffeine on EEG beta activity in nonREM sleep has previously been reported [281], where
the highest rise was in individuals with the CC genotype,
approximately half in the CT genotype, whereas no
change was present in the TT genotype. Consistent with
this observation, the same study found individuals with
the CC and TC genotypes appeared to confer greater
sensitivity towards caffeine-induced sleep disturbance
compared to the TT genotype [281]. This suggests that a
common variant in ADORA2A contributes to subjective
and objective responses to caffeine on sleep.

increased injury risk [294]. Athletes who are more prone
to performance anxiety may exacerbate their risk for
feelings of anxiety depending on their caffeine use and
which variant of the ADORA2A gene they possess. Monitoring the actions of caffeine in those individuals who
are susceptible, may alleviate some of the related feelings
of anxiety with caffeine use. Given that anxiety may disrupt concentration and sleep and negatively impact social interactions, athletes with higher risks and
prevalence for anxiety, may want to limit or avoid caffeine consumption (if caffeine is a known trigger) during
times where they are feeling anxious or stressed, such as
at sporting competitions or social gatherings or other
work and school events.
The importance of both sleep and caffeine (as an ergogenic aid) to athletes highlights the importance of optimizing rest and recovery through a better understanding
of which athletes may be at greater risk of adverse effects
of caffeine on mood and sleep quality, possibly due to
genetic variation. This information will allow athletes
and coaching staff to make informed decisions on when
and if to use caffeine when proximity to sleep is a factor.
These considerations will also be in conjunction with
the possibility that an athlete will benefit from caffeine
in endurance-based exercise as determined in part, by
their CYP1A2 genotype, albeit with a clear need for future research.

Caffeine, genetics and anxiety

Habitual caffeine intake

In elite athletes, 50% face mental health issues sometime
during their career [290]. Given that anxiety may be normalized in elite sports even at clinical levels, factors that
contribute to anxiety should be mitigated whenever possible. Anxiety may be caused by stress-related disorders
(burnout), poor quality sleep patterns (often related to caffeine intakes) and possibly as a response to caffeine ingestion due to genetic variation, even at low levels [109].
As previously mentioned, caffeine blocks adenosine receptors, resulting in the stimulating effects of caffeine
[213]. A common variation in the ADORA2A (adenosine
A2A receptor) gene contributes to the differences in subjective feelings of anxiety after caffeine ingestion [291,
292], especially in those who are habitually low caffeine
consumers [293]. This may be particularly relevant to
athletes who possess the TT variant of rs5751876 in the
ADORA2A gene. These individuals are likely to be more
sensitive to the stimulating effects of caffeine and experience greater increases in feelings of anxiety after caffeine
intake than do individuals with either the CT or CC
variant [291–293].
Sport psychologists commonly work with athletes to
help them overcome anxiety about performance during
competitions. Anxiety before or during athletic competitions can interfere not only in performance, but also in

The quantification of habitual caffeine intake is difficult,
which is problematic for studies aiming to compare performance outcomes following caffeine ingestion in habitual versus non-habitual caffeine users. This concern is
highlighted by reports showing large variability in the
caffeine content of commonly consumed beverages, e.g.
~ 8- to 9-fold differences in caffeine content have been
reported in coffee beverages purchased from similar retail shops [295] and in pre-workout supplements [296].
Self-reported intakes may therefore be unreliable. Newly
discovered biomarkers of coffee consumption may be
more useful for quantifying intakes in the future, but
currently, these are not widely available [297]. Different
protocols for the length of the caffeine abstinence period
preceding data collection is also a relevant factor in determining variability in performance outcomes. For example, in shorter caffeine abstinence periods e.g., 12–48
h, reversal of caffeine withdrawal effects by acute caffeine supplementation may have positive effects on performance, i.e. alleviating the negative symptoms of
withdrawal, which in itself may improve performance
[298]. These effects may be more pronounced in those
genetically predisposed to severe withdrawal effects
[299]. However, in one study 3 mg/kg caffeine significantly improved exercise performance in trained cyclists
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(n = 12), irrespective of whether a 4-day withdrawal
period was imposed on habitual caffeine users [300]. Another study also reported increased endurance in habitual caffeine users (n = 6) regardless of a 0, 2- or 4-day
abstinence period. The authors concluded that improved
performance under caffeine conditions at 6 mg/kg is not
related to prior caffeine habituation in recreational athletes [301]. Although genes have been associated with
habitual caffeine intake using GWAS research [302,
303], it is important to highlight that these associations
are not directly applicable to determining differences in
performance outcomes in response to acute caffeine
doses for regular or habitual caffeine users versus nonhabitual users. The “caffeine habits” of individuals are
more likely related to their personal experience with adverse effects such as feel jittery, experiencing tachycardia
or insomnia. Furthermore, associations between genes
and habitual caffeine intake do not elucidate potential
mechanisms by which caffeine intake behaviors may influence subsequent performance following caffeine supplementation [304, 305]. In animal model studies,
regular consumption of caffeine has been associated with
an upregulation of the number of adenosine receptors in
the vascular and neural tissues of the brain [306]. Although, this did not appear to modify the effects of caffeine in one study [307], in another, chronic caffeine
ingestion by mice caused a marked reduction in locomotor exploratory activity [308]. Changes in adenosine
receptor number or activity have not been studied in
humans.
There does not appear to be a consistent difference in
the performance effects of acute caffeine ingestion between habitual and non-habitual caffeine users, and
study findings remain equivocal. In one study, habitual
stimulation from caffeine resulted in a general dampening of the epinephrine response to both caffeine and exercise; however, there was no evidence that this
impacted exercise performance [309]. Another study
[310] examined the effect of 4 weeks of caffeine supplementation on endurance performance in 18 low-habitual
caffeine consumers who were randomly assigned to ingest caffeine or placebo for 28 days. Four weeks of caffeine ingestion resulted in increased tolerance to acute
caffeine supplementation in previously low habitual caffeine consumers, with the ergogenic effect of acute caffeine supplementation no longer apparent [310]. These
results are in contrast with a recent study in which 20
days of consecutive supplementation with caffeine maintained an ergogenic effect, even though the effect size attenuated over time [311]. More recently, a double-blind,
crossover, counterbalanced study was performed [312],
where 40 endurance-trained male cyclists were allocated
into tertiles according to their daily caffeine intake: low
(58 ± 29 mg), moderate (143 ± 25 mg), and high
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consumers (351 ± 139 mg). Participants completed three
trials in which they performed simulated cycling timetrials under three conditions: caffeine (6 mg/kg), placebo,
and no supplement (control). Caffeine ingestion improved performance as compared to placebo and control, with no influence of habitual caffeine intake.
Additionally, no correlation was observed between habitual caffeine intake and absolute changes in a ~ 30 min
cycling time-trial performance with caffeine [312]. However, a limitation of this study is the short 24-h caffeine
withdrawal period in all groups which may have resulted
in performance improvements due to the reversal of caffeine withdrawal effects, rather than impact of acute-onchronic caffeine administration and the effects of habituation to caffeine on exercise performance [298, 313]. In
addition, habitual caffeine intake was estimated using a
food frequency questionnaire, which might be a limitation given the already mentioned variation of caffeine in
coffee and different supplements.
There is wide variability in caffeine content of commonly consumed items, and as such, an objective measure (e.g., caffeine or metabolite levels) might be
considered to reported caffeine intakes [297, 313]. Based
on these observations, the assumption that habitual and
nonhabitual caffeine consumers will or will not respond
differently to caffeine supplementation during exercise,
requires further study.
Caffeine timing

The most common timing of caffeine supplementation
is 60 min before exercise. This timing is used given that
it is believed that 60 min post-ingestion, plasma levels of
caffeine are at maximal values [314]. However, caffeine
appears to be most beneficial during times or in sports
where there is an accumulation of fatigue, i.e., exercise
over a longer continuous or intermittent duration [64].
Therefore, ingestion of caffeine during exercise (mid/
later stages) may be more beneficial than ingestion beforehand for some individuals depending upon the
length of the event. A recent review [195] reported that
the effect size of caffeine benefits increase with the increasing duration of the time trial event, meaning that
timing caffeine intake closer to a time of greater fatigue,
i.e., later in the race, may be most beneficial. This supports the notion that endurance athletes (with longer
races) may benefit most from caffeine for performance
enhancement since they have the greatest likelihood of
being fatigued. This also supports findings in other investigations that show ingesting caffeine at various time
points including late in exercise may be most beneficial
[196].
For example, an early study [196] aimed to understand
whether or not there were benefits to a common practice among endurance athletes, such as those
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participating in marathons and triathlons, which is to
drink flat cola toward the end of an event. When researchers investigated the ingestion of a low dose of caffeine toward the end of a race (e.g., in the form of flat
cola) it was found to have comparable effects as ingesting higher doses, such as ~ 5 or 6 mg/kg, ingested ~ 60
min before the race. The study also demonstrated that
the effect was due to the caffeine and not the carbohydrate, which may also aid performance as fuel stores become depleted [196].
More recently, caffeine gum ingestion enhanced cycling performance when it was administered immediately
prior to exercise, but not when administered 1 or 2 h beforehand. This may have been due to the faster absorption with caffeinated gum consumption, and due to the
continued increase in plasma caffeine concentrations
during the cycling time trial, when athletes may become
fatigued (i.e. 30 + minutes into exercise), as the trials also
included a 15 min steady-state cycling bout prior to the
time trial [60]. Similarly, in a lab setting, a study of athletes completing 120 min of steady-state cycling followed
by a time trial under conditions of placebo and caffeine,
found that the ingestion of both low and moderate doses
of caffeine later in exercise were beneficial [149]. However, there was significant interindividual variability,
highlighting the need for athletes to experiment with
their own strategies as far as dosing and timing are
concerned.
The optimal timing of caffeine ingestion may depend
on the source of caffeine. As stated earlier, some of the
alternate sources of caffeine such as caffeine chewing
gums may absorb more quickly than caffeine ingested in
caffeine-containing capsules [60]. Therefore, individuals
interested in supplementing with caffeine should consider that timing of caffeine ingestion will likely be influenced by the source of caffeine.
Training status

Training status may mediate the magnitude of caffeine’s
ergogenic effect, but studies have reported mixed results.
Although a 2010 meta-analysis [158] did not find differences (p = 0.08) in caffeine’s ability to enhance muscle
endurance in untrained subjects versus trained subjects,
these results were not derived from direct comparisons
between trained and untrained subjects. Currently, only
a few investigations [96, 210, 315–318] have included
both trained and untrained subjects in their study
design.
In a study of elite and occasional swimmers [318], it
was reported that 250 mg of supplemental caffeine was
ergogenic only for competitive swimmers and not recreational swimmers. A limitation of this study is that the
swimming exercise task differed between the trained and
untrained participants. Specifically, the study utilized
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1600-m swimming for the trained swimmers and 400-m
for the untrained swimmers, which is a likely explanation for these findings. However, some have also postulated that this is because athletes perform more reliably
on a given task than nonathletes, and increased testretest reliability might prevent type II errors [319]. In
contrast to the above evidence regarding the importance
of training status, other research has shown that training
status does not moderate the ergogenic effects of caffeine on exercise performance. One study [210] showed
similar performance improvements (1.0 and 1.1%) in 15
well-trained and 15 recreational runners performing an
outdoor 5 km time trial after 5 mg/kg caffeine intake
compared to the placebo trial. Similarly, Astorino et al.
[96] found that overall, acute caffeine intake improved
10 km time-trial performance in both endurance-trained
athletes and active men, with no differences seen between groups. Likewise, an investigation concluded that
there was no ergogenic effect of caffeine at a dose of 5
mg/kg on time to exhaustion in either endurance trained
or untrained men [315].
More recently, a small study by Boyett et al. [317] investigated the interactions of 6 mg/kg caffeine on training status and time of day in 20 male subjects. Subjects
completed four experimental trials consisting of a 3-km
cycling time trial performed in randomized order for
each combination of time of day (morning and evening)
and treatment. They reported that both untrained and
trained subjects improved performance with caffeine
supplementation in the morning; however, only the untrained subjects improved when tested in the evening.
Although there were some limitations to this study,
these observations indicate that trained athletes are
more likely to experience ergogenic effects from caffeine
in the morning, while untrained individuals appear to receive larger gains from caffeine in the evening than their
trained counterparts. This may further complicate the
training status data with a possible temporal effect [317].
The concentration of adenosine receptors (the primary
target of caffeine) do appear to be higher in trained
compared to untrained individuals, but this has only
been reported in animal studies [320]. Boyett et al. [317]
speculated that the higher concentration of adenosine
receptors may increase tissue sensitivity to any given
concentration of adenosine.
Although some studies comparing training status of
subjects support the notion [318] that training influences
response to caffeine during exercise, most do not [96,
210, 315] and this was also the finding in a subsequent
meta-analysis [158]. It is possible that the only difference
between trained and untrained individuals is that trained
individuals likely have the mental discipline to exercise
long or hard enough to benefit more from the caffeine
stimulus, which might provide an explanation for why in
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some studies, trained individuals respond better to caffeine [314]. Currently, it seems that trained and untrained individuals experience similar improvements in
performance following caffeine ingestion; however, more
research in this area is warranted.
Caffeine and sleep

The impacts of caffeine on sleep and behavior after sleep
deprivation are widely reported [321]. Sleep is recognized as an essential component of physiological and
psychological recovery from, and preparation for, highintensity training in athletes [322, 323]. Chronic mild to
moderate sleep deprivation in athletes, potentially attributed to caffeine intakes, may result in negative or altered
impacts on glucose metabolism, neuroendocrine function, appetite, food intake and protein synthesis, as well
as attention, learning and memory [323]. These factors
can all influence an athlete’s nutritional, metabolic, and
endocrine status negatively and hence potentially affect
energy levels, muscle repair, immunity, body composition, memory and learning and result in diminished athletic performance [324, 325].
Objective sleep measures using actigraphy or carried
out in laboratory conditions with EEG have shown that
caffeine negatively impacts several aspects of sleep quality such as: sleep latency (time to fall asleep), WASO
(wake time after sleep onset), sleep efficiency and duration [321]. Studies in athletes have also shown adverse
effects in sleep quality and markers for exercise recovery
after a variety of doses of caffeine ingestion [326–328].
Although caffeine is associated with sleep disturbances,
caffeine has also been shown to improve vigilance and
reaction time and improved physical performance after
sleep deprivation [282, 329–332]. This may be beneficial
for athletes or those in the military who are traveling or
involved in multiday operations, or sporting events and
must perform at the highest level under sleep-deprived
conditions [192, 194, 330, 332].
Even though caffeine ingestion may hinder sleep quality, the time of day at which caffeine is ingested will
likely determine the incidence of these negative effects.
For example, in one study that included a sample size of
13 participants, ingestion of caffeine in the morning
hours negatively affected sleep only in one participant
[333]. However, ingestion of caffeine in the late afternoon (18:00 h) resulted in insomnia effects among 6 participants. These results are likely explained by the halflife of caffeine, which is generally around 4 to 6 h (even
though it varies between individuals). Unfortunately, athletes and those in the military are unlikely to be able to
make adjustments to the timing of training, competition
and military exercises or the ability to be combat ready.
However, to help avoid negative effects on sleep, athletes
may consider using caffeine earlier in the day whenever
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possible. Pronounced individual differences have also
been reported where functional genetic polymorphisms
have been implicated in contributing to individual sensitivity to sleep disruption [280, 281] and caffeine impacts
after sleep deprivation [282] as discussed in the Interindividual variation in response to caffeine: Genetics section of this paper.
Side-effects associated with caffeine intake

As with any supplement, caffeine ingestion is also associated with certain side-effects. Some of the most commonly
reported side-effects in the literature are tachycardia and
heart palpitations, anxiety [281, 291], headaches, as well as
insomnia and hindered sleep quality [239, 326]. For example, in one study, caffeine ingestion before an evening
Super Rugby game resulted in a delay in time at sleep onset and a reduction in sleep duration on the night of the
game [327]. Caffeine ingestion is also associated with increased anxiety; therefore, its ingestion before competitions in athletes may exacerbate feelings of anxiety and
negatively impact overall performance (see caffeine and
anxiety section). Increased jitters/anxiety/arousal associated with caffeine ingestion also needs to be considered
within the specific demands of each sport, and even the
position within a given sport. For example, athletes competing in sports that heavily rely on the skill component
(e.g., tennis players, biathlon shooting) would likely not
benefit from caffeine-induced jitters and arousal. However, athletes in sports that depend more on physical capabilities, such as strength and endurance (e.g., football
lineman), might actually benefit from increased jitters and
arousal before games. These aspects are less explored in
research but certainly warrant consideration in the practical context to optimize the response to caffeine supplementation. The primary determinant in the incidence and
severity of side-effects associated with caffeine ingestion is
the dose used. Side-effects with caffeine seem to increase
linearly with the dose ingested [239]. Therefore, they can
be minimized—but likely not fully eliminated—by using
smaller doses, as such doses are also found to be ergogenic
and produce substantially fewer side-effects [112]. In summary, an individual case-by-case basis approach is warranted when it comes to caffeine supplementation, as its
potential to enhance performance (benefit) needs to be
balanced with the side-effects (risk).
Caffeine and cognitive performance

In addition to exercise performance, caffeine has also
been studied for its contribution to athletes of all types
(including Special Forces operators in the military) who
are routinely required to undergo periods of sustained
cognitive function and vigilance due to their job requirements (Table 1). A 2016 review [344] concluded that
caffeine in doses from 32 to 300 mg (for a 75 kg
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individual) enhanced specific aspects of cognitive performance, such as attention, vigilance, and reaction time.
Spriet [112] also concluded that lower doses of caffeine
(approximately 200 mg) improved cognitive processes
associated with exercise including vigilance, alertness,
and mood. Hogervorst et al. [82] studied 24 well-trained
cyclists that were randomized to 3 groups: (1) consumed
a bar containing 45 g of carbohydrate and 100 mg of caffeine; (2) an isocaloric non-caffeine performance bar; or,
(3) a placebo beverage (non-caloric flavored water) immediately before performing a 2.5-h ride followed by a
time to exhaustion trial. They found that caffeine in a
carbohydrate-containing performance bar significantly
improved both endurance performance and complex
cognitive ability during and after exercise [82]. Antonio
et al. [345] assessed the effects of an energy drink on
psychomotor vigilance in a small cohort of 20 exercisetrained men and women. The acute consumption of 300
mg of caffeine in a commercially available energy drink
produced a significant improvement in psychomotor
vigilance mean reaction time in these subjects compared
to the placebo trial. This matches a 2001 IOM report
[346] that the effects of caffeine supplementation include
increased attention and vigilance, complex reaction time,
and problem-solving and reasoning.
One confounding factor on cognitive effects of caffeine
is the role of sleep. Special Forces military athletes conduct operations where sleep deprivation is common. A
series of different experiments [42, 329, 330, 332, 334,
335, 346, 347] have examined the effects of caffeine in
real-life military conditions. In three of the studies [329,
330, 334], soldiers performed a series of tasks such as a
4 or 6.3 km run and a marksmanship test, which is a task
that requires fine motor coordination and steadiness, observation/reconnaissance, and requires long periods of
no movement coupled with alertness and psychomotor
vigilance over several days, where opportunities for sleep
became more infrequent. Caffeine was provided at doses
ranging from 600 to 800 mg in the form of chewing
gum, owing to its practicality, i.e., rapid absorption and
portability [58]. The investigators found that vigilance
was either maintained or enhanced under the caffeine
conditions (vs. placebo), in addition to improvements in
run times and obstacle course completion [329, 330,
334]. Similarly, Lieberman et al. [42] examined the effects of caffeine on cognitive performance during sleep
deprivation in U. S. Navy Seals. During this investigation, there were multiple doses of caffeine ingested, 100
mg, 200 mg, or 300 mg, in capsule form. Once again, results were also significant for the assessments related to
vigilance and reaction time in both the 200 and 300 mg
caffeine intervention, suggesting smaller successive doses
of caffeine are more beneficial than large boluses, for improving focus and vigilance.
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The positive effects of caffeine on cognitive function
were further supported by work from Kamimori et al.
[332] where 20 special forces operators were randomly
assigned to receive four 200-mg doses of caffeine or placebo during a period of low sleep over three successive
days. The caffeine intervention maintained psychomotor
speed, improved event detection, increased the number
of correct responses to stimuli, and increased response
speed during logical reasoning tests. Under similar conditions of sleep deprivation, Tikuisis et al. [335] demonstrated that the cognitive component of a shooting task
(i.e., target detection) benefited from caffeine. These
studies [42, 329, 330, 332, 334, 335, 346, 347] demonstrate the effects of caffeine on vigilance and reaction
time in a sleep deprived state, in a distinct and highly
trained population, usually with repeated ‘lower’ doses,
~ 200 mg of caffeine ingestion. When subjects are not
sleep deprived, the effects of caffeine on cognition appear to be less effective. For example, Share et al. [336]
did not show any difference in shooting accuracy, reaction time, or target tracking times among the three
intervention trials using 2 escalating doses of caffeine at
2 mg/kg and 4 mg/kg.
In addition to the ability of caffeine to counteract the
stress from sleep deprivation, it may also play a role in
combatting other stressors. Gillingham et al. [339]
showed that in 12 reservists who ingested 5 mg/kg body
mass of caffeine or placebo 1 h pre- and post-strenuous
exercise, that caffeine ingestion mediated stress from
sleep deprivation cited above. However, these benefits
were not observed during more complex operations
[339]. With a different stressor (a simulated firefight), no
cognitive effect was seen with a caffeine dose of 400 mg
[340]. Crowe et al. [341] examined the effects of caffeine
(6 mg/kg dose) on cognitive parameters (visual reaction
time and number recall tests) via two maximal 60-s
bouts of cycling over three conditions (caffeine, placebo,
control). Again, no cognitive benefit was observed.
Other studies [244, 338, 342, 343] support the effects
of caffeine on the cognitive aspects of sport performance, even though with some mixed results [348, 349].
Foskett et al. [244] determined that a moderate dose (6
mg/kg) of caffeine enhanced the fine motor skills in soccer players as measured by improved ball passing accuracy and control. This was supported by Stuart et al.
[342] who examined the effects of the same dose of caffeine (6 mg/kg) and found a 10% improvement in ballpassing accuracy. Equivocal results were reported for
distance covered, agility, and accuracy in a review of 19
studies where caffeine ingestion before exercise was between 3 and 6 mg/kg [348]. Data on reactive agility time
is split, with one study demonstrating a benefit [343]
and another one [349] did not showing any benefit, despite using the same dose of caffeine (6 mg/kg). Finally,
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Table 1 Summary of studies that explored the effects of caffeine on cognitive function
Author

Participants

Protocol

Outcome

Sleep Deprived
Hogervorst
et al. 2008
[82]

Well-trained
cyclists (n = 24)

• Bar with 100 mg caffeine and 45.0 g CHO
• Bar with only 45.0 g CHO
• 300 mL non-caloric beverage

*↑Stroop and Rapid Visual Information Processing tests
after 140 min and time to exhaustion exercise trial at
75% VO2max

McLellan
et al. 2007
[334]

Soldiers (n = 20)

• 600 mg total caffeine in 200 mg does over 6 h
period
• Placebo

*↑ Increased vigilance

McLellan
et al. 2005
[329]

Soldiers (n = 31)

• 200 mg caffeine (gum) mg doses over 5 h
• Placebo

Maintained vigilance in control observation and
reconnaissance vigilance task

McLellan
et al. 2005
[330]

Soldiers (n = 30)

• 600 mg total caffeine in 100 mg and 200 mg
doses over a 6 h period
• Placebo

Sustained marksmanship vigilance and accuracy
*less decrease in urban operations vigilance

Lieberman
et al. 2002
[42]

U.S. Navy SEAL
trainees (n = 68)

• 100 mg caffeine
• 200 mg caffeine
• 300 mg caffeine
• Placebo

*↑improved vigilance and reaction time in both the
200 and 300 mg caffeine interventions following 72 h
sleep deprivation

Kamimori
et al. 2015
[332]

Special Forces
Operators (n = 20)

• Four 200 mg doses of caffeine
• Placebo

*maintained psychomotor speed, improved event
detection, increased the number of correct responses
to stimuli, and increased response speed during logical
reasoning tests.
⬌Live-fire marksmanship was not altered by caffeine.

Tikuisis
et al. 2004
[335]

Young Military
Subjects (n = 20)

• 400 mg caffeine
• 100 mg caffeine
• 100 mg of caffeine
• Placebo

*increased cognitive component of shooting task

Not Sleep Deprived
Share et al.
2009 [336]

Elite male shooters • 2 mg/kg caffeine
(n = 7)
• 4 mg/kg caffeine
• Placebo

⬌ shooting accuracy, reaction time, or target tracking
time between groups

Pomportes
et al. 2019
[337]

Modern
pentathlon
national team
athletes (n = 10)

• Four counterbalanced sessions with:
• 30 g CHO
• 300 mg guarana complex
• 200 mg caffeine
• Placebo

* enhanced speed of information processing w CHO,
and caffeine and guarana complex
* lower RPE w caffeine and gaurana complex

Duncan
et al. 2019
[228, 338]

Younger males
(n = 12)

• 5 mg/kg dose caffeine
• Placebo
60 min before 30 s upper body Wingate anaerobic test

*Readiness to invest physical effort, and cognitive
performance
*Reduced rating of perceived exertion
⬌Response accuracy

Other Stressors
⬌ shoot accuracy, reaction time, or target tracking
time between groups

Share et al.
2009 [336]

Elite male shooters • 2 mg/kg caffeine
(n = 7)
• 4 mg/kg caffeine
• Placebo

Gillingham
et al. 2004
[339]

Military reservists
(n = 12)

Zhang
et al. 2014
[340]

Firefighters (n = 10) • 400 mg caffeine
• Menthol lozenges
• Placebo

Crowe
et al. 2006
[341]

Healthy subjects:
male (n = 12)
female (n = 5)

• 6 mg/kg caffeine
• Placebo

⬌ rating of perceived exertion

Foskett
et al. 2009
[244]

Male soccer
players (n = 12)

• 6 mg/kg of caffeine
• Placebo

* Enhanced fine motor skills via improved ball passing
accuracy and control

• 6 mg/kg caffeine
• Placebo

*Increased ball-passing accuracy

Stuart et al. Competitive male
2005 [342] rugby (n = 9)
Duvnjak-

• 5 mg/kg caffeine or placebo dosed before 2.5 h
*↑ marksmanship performance (engagement time and
loaded march plus 1 h sandbag wall construction task number of shots fired)
then re-dose of 2.5 mg/kg caffeine or placebo
⬌friend-foe discrimination

Moderately trained • 6 mg/kg caffeine

⬌ Change in perceived exertion, mood reaction time,
short-term memory, or retrieval memory

*Main effect for condition on decision time
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Table 1 Summary of studies that explored the effects of caffeine on cognitive function (Continued)
Author
Zaknich
et al. 2011
[343]

Participants

Protocol

male athletes (n =
10)

• Placebo

Outcome

Outcomes are bold caffeine group specific; * = significant difference, ↑ = improved performance, ⬌ no change, mg/kg = milligram per
kilogram, CHO = carbohydrate

caffeine (5 mg/kg) was shown to enhance cognitive performance after an upper-body Wingate test, which may
be beneficial in sports or occupational activities where
there is a need for anaerobic performance concurrent
with decision making (e.g. firefighting, military related
tasks, wheelchair basketball) [338].
The exact mechanism of how caffeine enhances cognition in relation to exercise is not fully elucidated and appears to work through both peripheral and central
neural effects [350]. In a study by Lieberman et al. [42],
8 h after caffeine administration, caffeine continued to
enhance motor learning and short-term memory via performance of repeated acquisition. Repeated acquisition
are behavioral tests in which subjects are required to
learn new response sequences within each experimental
session [351]. The researchers [42] speculated that caffeine exerted its effects from an increased ability to sustain concentration, as opposed to an actual effect on
working memory. Other data [352] were in agreement
that caffeine reduced reaction times via an effect on
perceptual-attentional processes (not motor processes).
This is in direct contrast to earlier work that cited primarily a motor effect [353]. Another study with a sugar
free energy drink showed similar improvements in reaction time in the caffeinated arm; however, they attributed it to parallel changes in cortical excitability at rest,
prior, and after a non-fatiguing muscle contraction
[354]. The exact cognitive mechanism(s) of caffeine have
yet to be elucidated.
Based on some of the research cited above, it appears
that caffeine is an effective ergogenic aid for individuals
either involved in special force military units or who
may routinely undergo stress including, but not limited
to, extended periods of sleep deprivation. Caffeine in
these conditions has been shown to enhance cognitive
parameters of concentration and alertness. It has been
shown that caffeine may also benefit sport performance
via enhanced passing accuracy and agility. However, not
all of the research is in agreement. It is unlikely that caffeine would be more effective than actually sleeping, i.e.
you cannot ‘outcaffeinate’ poor sleep.
Environmental influences on response to caffeine

Physical activity and exercise in extreme environments
are of great interest as major sporting events (e.g. Tour
de France, Leadville 100, Badwater Ultramarathon) are

commonly held in extreme environmental conditions.
Events that take place in the heat or at high altitudes
bring additional physiological challenges (i.e., cardiovascular strain, thermoregulation, diuresis) for athletes,
which may be potentially compounded if caffeine is consumed prior to and/or during training or competition in
such environments [355]. Nonetheless, caffeine is widely
used by athletes as an ergogenic aid when exercising or
performing in extreme environmental situations. The
current understanding of caffeine’s impact on exercise
performance is based largely on the findings of analyses
conducted in controlled, temperate environments,
whereas data collected on the ergogenic effect of caffeine
consumption by individuals performing in the heat or at
altitude are limited and have resulted in inconsistent
findings.
Heat

The ability to perform prolonged exercise is impaired in
hot and/or humid environments [355, 356]. The use of
caffeine in conjunction with exercise in the heat has
been proposed to increase the risk for various heatrelated illnesses with particular concerns regarding caffeine’s effect on body temperature and hydration status
[357]. Ely et al. [358] concluded that caffeine dosages as
high as 9 mg/kg did not substantially alter body heat balance during endurance exercise performance at 40 °C.
Further, a recent study demonstrated that while caffeine
ingestion increased blood lactate and heart rate during
exercise in the heat (42 °C and 20% relative humidity),
endurance capacity and thermoregulation were unaffected in both male and female participants [359]. Although caffeine may induce mild fluid loss, the majority
of research has confirmed that caffeine consumption
does not significantly impair hydration status, exacerbate
dehydration, or jeopardize thermoregulation (i.e., body
temperature regulation) when exercising in the heat
[360, 361].
Several trials have observed no benefit of acute caffeine ingestion on cycling and running performance in
the heat (Table 2) [265, 362, 364]. However, Ganio and
colleagues [365] found caffeine (2 dosages of 3 mg/kg) to
be similarly ergogenic under both cool (12 °C) and warm
(33 °C) environmental conditions. Likewise, others [366]
have reported a non-significant, yet notable, improvement in cycling time trial performance in the heat (35 °C
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and 25% relative humidity) after caffeine consumption
(3 mg/kg) compared with placebo ingestion. While caffeine’s effect on performance in the heat remains somewhat unclear to date, positive support exists for dosages
between 3 and 6 mg/kg. Further, there does not appear
to be sufficient evidence to interdict the use of caffeine
by individuals who exercise in heat if consumed in dosages of 9 mg/kg or less.
Altitude

It is well established that caffeine improves performance
and perceived exertion during exercise at sea level [260,
314, 368, 369]. Despite positive outcomes at sea level,
minimal data exist on the ergogenic effects or side effects of caffeine in conditions of hypoxia, likely due to
accessibility of this environment or the prohibitive costs
of artificial methods. To date, only four investigations
(Table 3) have examined the effects of caffeine on exercise performance under hypoxic conditions [211, 370–
372]. In an initial study by Berglund and colleagues
[370], caffeine (6 mg/kg) significantly improved 21 km
time trial performance 2300 m above sea level in 14
well-trained cross-country skiers. Likewise, [371] positive
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outcomes were reported after caffeine (4 mg/kg) ingestion on endurance performance in acute hypoxic conditions of 4300 m above sea level. Specifically, significant
improvements in time to exhaustion in eight young
adults cycling at 80% of their altitude specific VO2max
was reported. More recently, 13 skiers were examined at
an altitude of 2000 m above sea level and it was reported
that caffeine (4.5 mg/kg) significantly improved time to
exhaustion while double poling during cross-country skiing at 90% of altitude-specific VO2max [211]. In a more
recent double-blind, randomized, counterbalanced
cross-over investigation [372], seven adult males significantly improved time to exhaustion by 12% following
consumption of 4 mg/kg caffeine. Overall, results to date
appear to support the beneficial effects of caffeine supplementation that may partly reduce the negative effects
of hypoxia on the perception of effort and endurance
performance [211, 370–372].
Alternate caffeine sources

Sources other than commonly consumed coffee and caffeine tablets have garnered interest, including caffeinated
chewing gum, mouth rinses, aerosols, inspired powders,

Table 2 Summary of studies that explored the effects of caffeine on exercise performance in the heat
Author

Participants

Protocol

Outcome

Cohen et al.
1996 [362]

Endurance trained
competitive road racers
(male = 5; female = 2)

• Placebo
• 5 mg/kg caffeine
• 9 mg/kg caffeine

⬌ Running performance

Del Coso
et al. 2008
[363]

Endurance trained male
cyclists (n = 7)

• No fluid
• Water
• 6%CHO Solution
• No fluid + 6 mg/kg caffeine capsule
• Water + 6 mg/kg caffeine capsule
• 6%CHO solution + 6 mg/kg caffeine capsule

⬌ Maximal voluntary contraction in
heat
*↑ Maximal cycling power in heat
*↑ Maximal leg force via voluntary
activation ONLY in water + caffeine
and 6%CHO + caffeine

Cheuvront
et al. 2009
[364]

Healthy males (n = 10)

• 9.0 mg/kg caffeine
• Placebo

⬌ TT performance
⬌ RPE

Ganio et al.
2011 [365]

Male cyclists (n = 11)

• Participants consumed either 3 mg/kg caffeine or placebo
60 min prior to and after 45 min of the following trials (4
trials total; total 6 mg/kg):
• Warm environment (33 °C): 90 min cycling followed by 15
min performance trial
• Cool environment (12 °C): 90 min cycling followed by 15
min performance trial

Caffeine *↑ increased performance
versus placebo independent of
temperature

Roelands
et al. 2011
[265]

Trained male cyclists or
triathletes (n = 8)

• 6 mg/kg caffeine
• Placebo

⬌ Acute cycling TT performance

Pitchford
et al. 2014
[366]

Well-trained males (n = 9)

• 3 mg/kg caffeine
• Placebo

⬌cycling TT performance in heat

Suvi et al.
2017 [359]

Healthy males (n = 13) and
females (n = 10)

• 6 mg/kg caffeine
• Placebo

⬌ Time to walking exhaustion

Beaumont
et al. 2017
[310, 367]

Recreationally active males
(n = 8)

• 6 mg/kg caffeine
• Placebo

*↑ Endurance cycle performance in heat
*↓ RPE during initial 60 min of exercise

Outcomes are bold caffeine group specific; * = significant difference, ⬌ = no change, ↑ = improved performance, TT = time trial, mg/kg = milligram per kilogram,
CHO = carbohydrate, min = minutes, RPE = rating of perceived exertion
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Table 3 Summary of studies that explored the effects of caffeine on exercise performance at altitude
Author

Participants

Protocol

Outcome

Berglund et al. 1982
[370]

Well-trained cross-country skiers
(n = 14)

• 6 mg/kg
caffeine
• Placebo

*↑ 21 km TT 2900 m above sea level

Fulco et al. 1994
[371]

Young adult cyclists (n = 8)

• 4 mg/kg
caffeine
• Placebo

*↑ Time to exhaustion at 80% of their altitude-specific VO2max at 4300
m above sea level

Stadheim et al. 2015 Male sub-elite cross-country skiers • 4.5 mg/kg
[211]
(n = 13)
caffeine
• Placebo
Smirmaul et al. 2017
[372]

Adult male volunteers (n = 7)

• 4.0 mg/kg
caffeine
• Placebo

*↑ Double-poling time to task failure at 2000 m above sea level

*↑ Time to exhaustion during cycling by 12%

Outcomes are bold caffeine group specific; * = significant difference, ↑ = improved performance, TT = time trial, m = meters, mg/kg = milligram per kilogram

energy bars, energy gels and chews, among others. While
the pharmacokinetics [18, 373–376] and effects of caffeine on performance when consumed in a traditional
manner, such as coffee [47, 49, 55, 153, 368, 377, 378] or
as a caffeine capsule with fluid [55, 203, 379, 380] are
well understood, curiosity in alternate forms of delivery
(as outlined in pharmacokinetics section) have emerged
due to interest in the speed of delivery [81]. A recent review by Wickham and Spriet [5] provides an overview of
the literature pertaining to caffeine use in exercise, in alternate forms. Therefore, here we only briefly summarize
the current research.
Caffeinated chewing gum

Several investigations have suggested that delivering caffeine in chewing gum form may speed the rate of caffeine delivery to the blood via absorption through the
extremely vascular buccal cavity [58, 381]. Therefore,
caffeine via chewing gum may be absorbed via two passageways: the buccal mucosa in the oral cavity and/or
gut absorption due to the swallowing of caffeinecontaining saliva [58, 381, 382]. Kamimori and colleagues [58] compared the rate of absorption and relative
caffeine bioavailability from caffeinated chewing gum
and caffeine in capsule form. The results suggest that
the rate of drug absorption from the gum formulation
was significantly faster. In the groups ingesting 100 and
200 mg, both gum and capsule formulations provide
near comparable plasma caffeine concentrations to the
systemic circulation. These findings suggest that there
may be an earlier onset of pharmacological effects from
caffeine delivered through the gum formulation. Further,
while no data exist to date, it has been suggested that increasing absorption via the buccal cavity may be preferential over oral delivery if consumed closer to or during
exercise, as splanchnic blood flow is often reduced [383],
potentially slowing the rate of caffeine absorption.
To date, five studies [59–63] have examined the potential ergogenic impact of caffeinated chewing gum on

aerobic performance, commonly administered in multiple sticks (Table 4). To note, all studies have been conducted using cycling interventions, with the majority
conducted in well-trained cyclists. Results from these investigations suggest that caffeinated chewing gum delivered in total dosages ranging 200–300 mg, closer to
initiation of exercise or during a prolonged endurance
event may be most beneficial, specifically for individuals
with a higher training status. However, more research is
needed, especially in physically active and recreationally
training individuals.
Four studies [64, 66, 68, 384] have examined the effect
of caffeinated chewing gum on more anaerobic type activities (Table 4). Specifically, Paton et al. [64] administered 3 mg/kg caffeinated gum to male cyclists during
repeat sprint cycling, resulting in greater attenuation of
fatigue, compared to a placebo. The reduced fatigue in
the caffeine trials equated to a 5.4% performance enhancement in power during sprints, in favor of caffeinated gum. A study [384] assessing 100 mg caffeinated
chewing gum on shot-put performance during an early
morning trial resulted in overall improvements in shotput distance thrown compared to a placebo. Caffeinated
gum consumption also positively influenced performance in two out of three soccer-specific (Yo-Yo Intermittent Recovery Test and CMJ) tests used in the
assessment of performance in soccer players [66]. A recent study also explored the effects of 300 mg of caffeine
provided in caffeine chewing gum and found that its
consumption 10 min pre-exercise resulted in ergogenic
effects on jumping performance, isokinetic peak torque,
upper body movement velocity and whole-body power
output during a rowing test [68]. These results suggest
that caffeine chewing gums may provide ergogenic effects across a wide range of exercise tasks. To date, only
Bellar et al. [384] has examined chewing gum with caffeine on cognitive function, specifically reporting improved alertness as assessed by a psychomotor vigilance
test. Future studies may consider comparing the effects
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Table 4 Investigations examining the effects of caffeinated chewing gum on caffeine absorption and exercise performance
Author

Participants

Protocol

Results

Kamimori
et al. 2002
[58]

Healthy males (n = 84; 12
per group)

• 50 mg caffeine capsule
• 50 mg caffeine gum
• 100 mg caffeine capsule
• 100 mg caffeine gum
• 200 mg caffeine capsule
• 200 mg caffeine gum
• Placebo

Both 100 and 200 mg of caffeine in gum and capsule formualtions
provide comparable amounts of caffeine to the systemic circulation.
Mean Tmax for the gum groups ranged from 44.2 to 80.4 min as
compared with 84.0–120.0 min for the capsule groups

Ryan et al.
2012 [59]

College-aged, physically
active males (n = 8)

• 200 mg caffeinated gum
• Placebo gum

⬌ cycling TTE

Ryan et al.
2013 [60]

Well-trained male cyclists
(n = 8)

• 300 mg caffeine gum
• Placebo gum

*↑ cycling TT performance when 300 mg caffeine chewing gum was
administered 5 min pre-TT

Lane et al.
2014 [61]

Well-trained males (n =
12) and females (n = 12)

• 3 mg/kg caffeine gum 40
min prior + 1 mg/kg 10 min
prior
• Placebo gum
• Beet root juice
• Beet root juice w/ caffeine

*↑ cycling TT performance by 3–4%
Note: participant’s sex was accounted for during testing (female: 29.35
km; male: 43.83 km)

• 200 mg caffeine gum
• 200 mg caffeine + CHO
gum
• CHO gum
• Placebo gum

⬌ cycling TT performance

Oberlin-Brown Well-trained male cyclists
et al. 2016
(n = 11)
[62]

Paton et al.
2015 [63]

Well-trained male (n = 10) • ~ 3–4 mg/kg caffeine gum
and female (n = 10)
• Placebo gum
cyclists

Paton et al.
2010 [64]

Competitive male cyclists
(n = 9)

• 3 mg/kg caffeine gum
• Placebo gum

*↓ power output decline in 3rd & 4th sprints

Bellar et al.
2012 [65]

Collegiate shot-put athletes (n = 9)

• 100 mg caffeine gum
• Placebo gum

*↑ shot-put performance

Ranchordas
et al. 2018
[66]

Collegiate male soccer
players (n = 10)

• 200 mg caffeine gum
• Placebo gum

*↑ Yo-Yo Intermittent Recovery Test level 1 and countermovement
jump

Venier et al.
2019 [67, 68]

Resistance-trained men
(n = 19)

• 300 mg caffeine gum
• Placebo gum

*↑ Jumping height
*↑ Isokinetic strength and power
*↑ Movement velocity in the bench press
*↑ Whole-body power output

~ 3–4 mg/kg enhanced both endurance (> 5 min) and sprint power
output (< 30 s) by similar amounts (~ 4%) during the final 10 km of a 30km race

Bold text associated with reported trial outcomes; * delineates a significant change, NS = non-significant change, TT = Time Trial, TTE = time to exhaustion, ⬌ = no
improvement/change, ↑ = improved performance, ↓ = decreased, min = minute, CHO = carbohydrate, seg = segment, Tmax = maximum
concentration, km = kilometers

of caffeine in chewing gums to caffeine ingested in
capsules.
Caffeine mouth rinsing

Caffeine mouth rinsing (CMR; 5–20 s in duration) may
have the potential to enhance exercise performance due
to the activation of sensorimotor brain cortices [79].
Specifically, the mouth contains bitter taste sensory receptors that are sensitive to caffeine [385]. It has been
proposed that activation of these bitter taste receptors
may activate neural pathways associated with information processing and reward within the brain [385–387].
Physiologically, caffeinated mouth rinsing may also reduce gastrointestinal distress potential that may be
caused when ingesting caffeine sources [388, 389].
Few investigations on aerobic [69, 74–76, 390] and anaerobic [72, 73, 78] changes in performance, as well as

cognitive function [70, 71] and performance [77], following CMR have been conducted to date (Table 5). One
study [390] demonstrated ergogenic benefits of CMR on
aerobic performance, reporting significant increases in
distance covered during a 30-min arm crank time trial
performance. Likewise, in a separate study [74], a 5 s
CMR (containing 32 mg of caffeine dissolved in 125 ml
water) improved 30 min cycling performance, without
concurrent increases in ratings of perceived exertion or
heart rate. With regard to anaerobic trials, other researchers [72] have also observed improved performance, where recreationally active males significantly
improved their mean power output during repeated 6-s
sprints after rinsing with a 1.2% caffeine solution. A
follow-up study [73] reported that recreationally active
males who were deemed ‘glycogen depleted’ increased
mean and peak power during the 3rd sprint of repeat
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Table 5 Investigations examining the effects of caffeine mouth rinsing (CMR) on exercise performance
Author

Participants

Protocol

Results

Doering et al.
2014 [69]

Well-trained cyclists (n = 10)

• 10 s rinse 35 mg caffeine/
25 mL X 8
• Placebo rinse

⬌ plasma caffeine levels
⬌ cycling TT Performance

De Pauw et al.
2015 [70]

Healthy males (n = 10)

• 20 s- 25 mL Rinse 1.2%
caffeine
• 20 s- 25 mL Rinse 6.4% CHO
• Placebo Rinse

*↑ stroop task performance

Pomportes
Physically active males (n = 16)
et al. 2017 [71] and females (n = 6)

• 20 s- 25 mL rinse 67 mg
caffeine
• 20 s- 25 mL rinse 7.0%
CHO
• 20 s- 25 mL rinse 0.4 g
guarana
• Placebo rinse

⬌ variability or production durations
⬌ errors made

Beaven et al.
2013 [72]

Recreationally active males
(n = 12)

• 5 s- 25 mL rinse 1.2%
caffeine
• 5 s- 25 mL rinse 6% CHO
• Placebo rinse

*↑ mean power in first sprint for caffeine and CHO rinses
NS ↑ maximal power in first two sprints

Beaven et al.
2013 [72]

Recreationally active males
(n = 12)

• 5 s- 25 mL rinse 1.2%
caffeine
• 5 s- 25 mL rinse 6.0% CHO
• 5 s- 25 mL rinse 1.2%
caffeine
+ 6.0% CHO

*↑ peak power in first sprint
*↑ mean power in fifth sprint

Kizzi et al.
2016 [73]

Glycogen depleted,
recreationally active males
(n = 8)

• 10 s- 25 mL rinse 2.0%
caffeine
• Placebo rinse

⬌ mean and peak power in 4th and 5th sprint

Sinclair and
Bottoms 2014
[74]

Healthy males (n = 12)

• 5 s- 25 mL rinse 0.032%
*↑ arm crank TT performance
caffeine
• 5 s- 25 mL rinse 6.4% CHO
• Placebo rinse

Bottoms et al.
2014 [74]

Healthy males (n = 12)

• 5 s- 125 mL rinse w/ 32 mg
of caffeine
• 5 s – 6.4% CHO solution
• Placebo rinse

Pataky et al.
2016 [75]

Recreationally trained male
(n = 25) and female (n = 13)
cyclists

• Placebo rinse + 6 mg/kg
*↑ 3 km cycling TT performance
caffeine capsule
• 25 mL rinse 300 mg caffeine
+ placebo capsule
• 25 mL rinse 300 mg
caffeine + 6 mg/kg caffeine
capsule

Lesniak et al.
2016 [76]

Recreationally active females
(n = 7)

• 5 s- 25 mL rinse 1.2%
caffeine
• 5 s- 25 mL rinse 6.0% CHO
• 5 s- 25 mL rinse 1.2%
caffeine
+ 6% CHO

⬌ cycling TT performance

Dolan et al.
2017 [77]

College lacrosse players (n =
10)

• 5 s- 25 mL Rinse 1.2%
caffeine
• 5 s- 25 mL Rinse 6.0% CHO
• 5 s- 25 mL Rinse 1.2%
caffeine
+ 6.0% CHO
• Placebo rinse
• No rinse

⬌ intermittent sport performance

Clarke et al.
2015 [78]

Recreationally resistancetrained males (n = 15)

• 5 s- 25 mL rinse 1.2%
caffeine
• 5 s- 25 mL rinse 6.0% CHO
• 5 s- 25 mL rinse 1.2%
caffeine
+ 6.0% CHO

⬌ total weight lifted

*↑ distance cycled during the caffeine mouth rinse trial (16.2 ± 2.8
km) was significantly greater compared to placebo trial (14.9 ± 2.6
km).
There was no difference between CHO and caffeine trials
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Table 5 Investigations examining the effects of caffeine mouth rinsing (CMR) on exercise performance (Continued)
Author

Participants

Protocol

Results

• Placebo rinse
Bold text associated with reported trial outcomes; s = seconds, mL = milliliters, CHO = carbohydrate, TT time trial, * = significant difference, NS = non-significant
difference, ↑ = improved performance, ↓ = decreased, ⬌ = no improvement/change, mg = milligrams

cycling, as well as decreased perception of pain during
the 4th and 5th sprints following a 10 s rinse of a 2% caffeine rinse. While CMR has demonstrated positive outcomes for cyclists, another study [78] in recreationally
resistance-trained males did not report any significant differences in the total weight lifted by following a 1.2% caffeine rinse. CMR appears to be ergogenic in cycling to
include both longer, lower-intensity and shorter highintensity protocols. The findings on the topic are equivocal likely because caffeine provided in this source does not
increase caffeine plasma concentration and increases in
plasma concentration are likely needed to experience an
ergogenic effect of caffeine [69]. Details of these studies, as
well as additional studies may be found in Table 5.
Caffeinated nasal sprays and inspired powders

The use of caffeinated nasal sprays and inspired powders
are also of interest. Three mechanisms of action have
been hypothesized for caffeinated nasal sprays. Firstly,
the nasal mucosa is permeable, making the nasal cavity a
potential route for local and systemic substance delivery;
particularly for caffeine, a small molecular compound
[11, 12, 30, 31]. Secondly, and similar to CMR, bitter
taste receptors are located in the nasal cavity. The use of
a nasal spray may allow for the upregulation of brain activity associated with reward and information processing
[391]. Thirdly, but often questioned due to its unknown
time-course of action, caffeine could potentially be
transported directly from the nasal cavity to the CNS,
specifically the cerebrospinal fluid and brain by intracellular axonal transport through two specific neural pathways, the olfactory and trigeminal [392, 393].
In two separate trials [79, 80], the effects of caffeinated
nasal sprays containing 15 mg of caffeine per mL were
examined. No significant improvements were reported
in either anaerobic and aerobic performance outcome
measures despite the increased activity of cingulate, insular, and sensory-motor cortices [79]. Laizure et al. [81]
compared the bioavailability and plasma concentrations
of 100 mg caffeine delivered via an inspired powder
(AeroShot) and an oral solution. Both were found to
have similar bioavailability and comparable plasma concentrations with no differences in heart rate or blood
pressure (Table 6).

studies have yet to be conducted and only three experimental trials have been reported. Cooper et al. [83] and Scott
et al. [84] examined the effects of carbohydrate-caffeinated
gels, which both included 100 mg caffeine dosages alongside 25 g and 21.6 carbohydrate, respectively. In the study
by Cooper et al. the consumption of caffeinated gels 60 min
pre-exercise did not enhance intermittent sprint performance. In contrast, Scott et al. utilized a shorter time period
from consumption to the start of the exercise (i.e., 10 min
pre-exercise) and found significant improvements in 2000m rowing performance after consumption of caffeinated
gels. Another recent study utilized caffeine gels and found
that 300 mg of caffeine, provided 10 min pre-exercise increased vertical jump performance, strength, and power in
a sample of 17 resistance-trained men [67]. These results
tentatively suggest that timing of consumption is important
when it comes to caffeinated gels with ergogenic effects
found when consuming caffeine gels 10 min but not 60 min
before exercise. However, these ideas are based on results
from independent studies and therefore, future studies may
consider exploring the optimal timing of caffeine gel ingestion in the same group of participants. More details on
these studies may be found in (Table 7).
Caffeinated bars

Similar to caffeinated gels, no studies measured plasma caffeine concentration following caffeinated bar consumption;
however, absorption and delivery likely mimic that of coffee
or caffeine anhydrous capsule consumption. While caffeinated bars are commonly found in the market, research on
caffeinated bars is scarce. To date, only one study [82]
(Table 7) has examined the effects of a caffeine bar on exercise performance. Specifically, participants that consumed a
carbohydrate-bar containing 100 mg of caffeine significantly
improved their time to exhaustion during cycling compared
to a carbohydrate bar and placebo with no differences
found in ratings of perceived exertion, average heart rate
and relative exercise intensity. Furthermore, cyclists significantly performed better on complex information processing
tests following the time trial to exhaustion after caffeine bar
consumption when compared to the carbohydrate only
trial. As there is not much data to draw from, future work
on this source of caffeine is needed.

Caffeinated gels

Caffeine in combination with other ingredients
Caffeine and Creatine

While caffeinated gels are frequently consumed by runners,
cyclists and triathletes, plasma caffeine concentration

A review by Trexler and Smith-Ryan comprehensively
details research on caffeine and creatine co-ingestion
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Table 6 Investigations examining the effects of caffeine nasal sprays on exercise and cognitive performance
Author

Participants

Protocol

Results

De Pauw et al. 2017
[79]

Healthy males (n = 10)

• Nasal spray 15 mg/mL caffeine
• Nasal spray 80 mg/mL glucose
• Placebo nasal spray

*↑ activity of cingulate, insular, and sensory-motor
cortices
⬌ stroop task performance

De Pauw et al. 2017
[80]

Moderately trained males
(n = 11)

• Nasal spray 15 mg/mL caffeine
• Nasal spray 80 mg/mL glucose
• Placebo nasal spray

⬌ plasma caffeine levels
⬌ wingate performance
⬌ 30 min cycling TT performance
⬌ stroop task performance

Laizure et al. 2017
[81]

Healthy adults (n = 17)

• Inspired powder 100 mg/mL caffeine
(AeroShot)
• Oral solution 100 mg/248 mL caffeine

⬌ peak plasma caffeine levels
⬌ bioavailability

mg/mL = milligram per milliliter, TT = time trial, * = significant difference, ⬌ = no improvement/change, ↑ = increased, ↓ = decreased, min = minute

[32]. With evidence to support the ergogenic benefits of
both creatine and caffeine supplementation on human
performance—via independent mechanisms—interest in
concurrent ingestion is of great relevance for many athletes and exercising individuals [32]. While creatine and
caffeine exist as independent supplements, a myriad of
multi-ingredient supplements (e.g., pre-workouts) containing both caffeine and creatine are available. It has
been reported that the often-positive ergogenic effect of
acute caffeine ingestion prior to exercise is unaffected by
creatine when a prior creatine loading protocol had been
completed by participants [394, 395]. However, there is
some ambiguity with regard to the co-ingestion of caffeine during a creatine-loading phase (e.g., co-ingestion
of coffee and creatine) [396–399]. Studies available to
date suggest that high-dose chronic caffeine (> 9 mg/kg)
and creatine co-ingestion should be employed cautiously, as counteracting mechanisms on Ca2+ clearance
and release, and muscle relaxation time have been hypothesized [396, 398]. While favorable data exist on
muscular performance outcomes and adaptations in individuals utilizing multi-ingredient supplements (e.g.,

pre-workouts), these results may be confounded by
other ingredients (e.g., beta-alanine, citrulline malate,
amino acids) in the supplement [34, 95, 400, 401]. Until
future investigations are available, it may be prudent to
consume caffeine and creatine separately, or avoid high
caffeine intakes when utilizing creatine for muscular
benefits [402].
Caffeine and carbohydrate

To date, investigations examining the co-ingestion of
carbohydrate and caffeine compared with carbohydrate
alone prior to and/or during exercise have produced inconsistent results [196, 264, 403–405]. This is likely due
to the heterogeneity of experimental protocols that have
been implemented and examined. Nonetheless, a 2011
systematic review and meta-analysis of 21 investigations
[406] concluded the co-ingestion of carbohydrate and
caffeine significantly improved endurance performance
when compared to carbohydrate alone. However, it
should be noted that the magnitude of the performance
benefit that caffeine provides is less when added to
carbohydrate (i.e., caffeine + carbohydrate vs.

Table 7 Investigations examining the effects of caffeinated bars and gels on exercise performance
Author

Participants

Protocol

Results

Hogervorst et al. Well-trained male
2008 [82]
cyclists (n = 24)

• Bar with 100 mg caffeine *↑Stroop and Rapid Visual Information Processing tests after 140 min and
and 45.0 g CHO
time to exhaustion exercise trial at 75% VO2max
• Bar with only 45.0 g CHO
• 300 mL non-caloric
beverage

Cooper et al.
2014 [83]

• Gel with 100 mg caffeine *↓ fatigue and RPE during 3rd sprint set
and 25.0 g CHO
NS: sprint performance
• Gel with 25 g CHO
• Gel placebo

Recreationally trained
males (n = 12)

Scott et al. 2015 Male college athletes
[84]
(n = 13)

• Gel with 21.6 g CHO and
100 mg caffeine
• Gel with 21.6 g CHO

*↑ performance in 2000 m rowing task

Venier et al.
2019 [67, 68]

• Gel with 88 g CHO and
300 mg caffeine
• Gel with 88 g CHO

*↑ jumping height
*↑ isokinetic strength and power
*↑ movement velocity in the bench press
NS: whole-body power output

Resistance-trained
men (n = 17)

Bold text associated with reported trial outcomes; mg = milligrams, g = grams, CHO = carbohydrate, * = significant, NS = non-significant difference, VST = visual
sensitivity test, ↑ = improved performance, ↓ = decreased, m = meters, RPE = rating of perceived exertion, mL = milliliters
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carbohydrate) than when isolated caffeine ingestion is
compared to placebo [404]. Since the 2011 publication
[406], results remain inconclusive, as investigations related to sport-type performance measures [83, 250, 407–
411], as well as endurance performance [84, 367, 412]
continue to be published. Overall, to date it appears caffeine alone, or in conjunction with carbohydrate is a superior choice for improving performance, when
compared to carbohydrate supplementation alone.
While the majority of training or performing individuals would choose to supplement with caffeine prior to
exercise or during competition, interest in caffeine’s effect on muscle glycogen repletion during the postexercise period has garnered interest. Few studies to date
have investigated the effect of post-exercise caffeine consumption on glucose metabolism [413, 414]. While the
delivery of exogenous carbohydrate can increase muscle
glycogen alone, Pedersen et al. [413] report faster glycogen repletion rates in athletes who co-ingested caffeine
(8 mg/kg body mass) and carbohydrate (4 g/kg body
mass), compared to carbohydrate alone (4 g/kg body
mass). In addition, it has been demonstrated that coingestion of caffeine with carbohydrate after exercise improved subsequent high-intensity interval-running capacity compared with ingestion of carbohydrate alone.
This effect may be due to a high rate of post-exercise
muscle glycogen resynthesis [415]. The data to date indicate that caffeine may potentiate glycogen resynthesis
when high dosages of caffeine (~ 8 mg/kg body mass)
are consumed during the recovery phase of exercise;
though, when adequate carbohydrate is provided postexercise, caffeine may not provide any glycogenresynthesizing benefit [414]. Practically, caffeine ingestion in close proximity to sleep, coupled with the necessity to speed glycogen resynthesis, should be taken into
consideration, as caffeine before bed may cause sleep
disturbances.
Caffeine within brewed coffee

The genus of coffee is Coffea, with the two most common species Coffea arabica (arabica coffee) and Coffea
canephora (robusta coffee) used for global coffee production. While coffee is commonly ingested by exercising individuals as part of their habitual diet, coffee is
also commonly consumed pre-exercise to improve energy levels, mood, and exercise performance [11, 40]. Indeed, a recent review on coffee and endurance
performance, reported that that coffee providing between 3 and 8.1 m/kg of caffeine may benefit endurance
performance, such as time trial performance or time to
exhaustion [11]. To date, research has only examined
coffee’s effects on cycling and running exercise performance. Specifically, Higgins et al. [11] highlight that significant improvements over control conditions were
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found with doses up to 8.1 mg/kg; however, performance
benefits were similar to 3 mg/kg servings. Since the release of the Higgins et al. review, three additional studies
have been published, examining the effects of coffee on
exercise performance. Specifically, Niemen et al. [416]
assessed the impact of high chlorogenic acid coffee on
performance. Cyclists were asked to consume coffee or
placebo (300 ml/day) for 2 weeks prior to completing a
50-km time-trial. Chlorogenic acid coffee provided 1066
mg chlorogenic acid plus 474 mg caffeine, while the placebo consisted of 187 mg chlorogenic acid and 33 mg
caffeine. Fifty-km cycling time performance and power
did not differ between trials. Participant’s heart rate and
ventilation were higher with chlorogenic acid coffee during the time-trial, potentially provoking the nonsignificant performance outcomes. Regarding resistance
exercise performance, only two studies [55, 56] have
been conducted to date. One study [56] reported that
coffee and caffeine anhydrous did not improve strength
outcomes more than placebo supplementation. On the
other hand, Richardson et al. [55] suggested that coffee
consumption may improve lower-body muscular endurance performance similarly as isolated caffeine ingestion.
The results between studies differ likely because it is
challenging to standardize the dose of caffeine in coffee
as differences in coffee type and brewing method may
alter caffeine content [417]. Even though coffee may enhance performance, due to the difficulty of standardizing
caffeine content most sport dietitians and nutritionists
use anhydrous caffeine with their athletes due to the difficulty of standardizing caffeine content.
Caffeine containing energy drinks and pre-workouts

Consumption of energy drinks has become more common in the last decade, and several studies have examined the effectiveness of energy drinks as ergogenic aids
(Table 8). Souza and colleagues [418] completed a systematic review and meta-analysis of published studies
that examined energy drink intake and physical performance. Studies including endurance exercise, muscular
strength and endurance, sprinting and jumping, as well
as sport-type activities were reviewed. Dosages of caffeine ranged from 40 to 325 mg among the studies, with
the majority of drinks also containing taurine. While it
was concluded that energy drink consumption increased
performance in the aforementioned performance activities, the ergogenic effect was not solely attributed to the
amount of caffeine administered, but improved also as a
result of taurine content (dosages ranged 71 to 3105 mg)
[418]. This is similar to data from another study, reporting that Red Bull (500 ml serving; 160 mg of caffeine/
2.25 mg/kg), also containing taurine, glucose, glucuronolactone, and B vitamins, improved 5-km run performance in recreationally athletes [91]. It has been suggested
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Table 8 Energy drinks and pre-workout supplements
Endurance
Exercise
Performance

Author

Participants

Protocol

Results

Other supplements

Alford
et al.
2001 [85]

Young adults
(n = 36)

-250 mL Energy drink
with 80 mg caffeine
and 26 g CHO
-Carbonated placebo
-No drink

*↑ Aerobic Endurance

-26 g CHO

Candow
et al.
2009 [86]

Young men
(n = 9) and
women (n = 8)

-CHO free energy
drink with 2 mg/kg
caffeine
-Non-caffeinated
version of energy drink

⬌ High-intensity Run Time to
Exhaustion

Walsh
et al.
2010 [87]

Recreationally
active men (n =
9) and women
(n = 6)

-26 g Pre-workout
with unknown
amount of caffeine
(ingredients listed in
column 5)
-Placebo

*↑ Mod-intensity Run Time to
Exhaustion

−2.05 g taurine, caffeine, and
gluconolactone, 7.9 g L-leucine, Lisoleucine, L-valine, L-arginine and
L-glutamine, 5 g of di-creatine citrate, and 2.5 g of βalanine

Ivy et al.
2009 [88]

Trained cyclists -Energy drink with
men (n = 6) and 160 mg caffeine
women (n = 6)
-Placebo

*↑ Cycle Time Trial Performance by
4.7%

-2.0 g taurine, 1.2 g
glucuronolactone, 54 g
carbohydrate, 40 mg niacin, 10 mg
pantothenic acid, 10 mg vitamin
B6, and 10 microg vitamin B12

Sanders
et al.
2015 [89]

Healthy
participants
(n = 15)

−12 oz. Placebo (Squirt)
− 8.4 oz. Red Bull®
− 16 oz. Monster
Energy®
− 2 oz. 5-h ENERGY®

⬌ RPE on Treadmill at 70% VO2 max
⬌ Oxygen Consumption at 70% VO2
max

Al-Fares
et al.
2015 [90]

Healthy female
students (n =
32)

-Energy drink with
160 mg caffeine
-Placebo with similar
CHO content

⬌ VO2 max

−2.0 g taurine, 1.2 g
glucuronolactone, 54 g
carbohydrate, 40 mg niacin, 10 mg
pantothenic acid, 10 mg vitamin
B6, and 10 μg vitamin B12

*↑ 5 k Time Trial

−2.0 g taurine, 1.2 g
glucuronolactone, 54 g
carbohydrate, 40 mg niacin, 10 mg
pantothenic acid, 10 mg vitamin
B6, and 10 microg vitamin B12
-1870 mg (taurine, glucuronic acid,
malic acid, N-acetyl L-tyrosine, Lphenylalanine and citicoline)

Prins et al. Recreation
-Energy drink with
2016 [91] endurance male 160 mg caffeine
(n = 13) and
-Placebo
female (n = 5)
runners

Resistance/
Sprint
Performance

Kinsinger
et al.
2016 [92]

Recreational
male athletes
(n = 23)

−1.93 oz Energy shot
with 100 mg caffeine
− 1.93 oz. Placebo

⬌ RPE on Treadmill VO2 max Test
⬌ Treadmill VO2 max

Forbes
et al.
2007 [93]

Young men
(n = 11) and
women (n = 40

-Energy drink with 2
mg/kg caffeine
-Non-caffeinated
version of energy drink

*↑ Bench-Press Repetitions by 6%

Del Coso
et al.
2012 [94]

Healthy men
(n = 9) and
women (n = 3)

-Energy drink with 1
mg/kg caffeine
-Energy drink with 3
mg/kg caffeine
-Non-caffeinated
version of energy drink

*↑ Half-Squat Maximal Power by 7%
*↑ Bench-Press Maximal Power by 7%

Gonzalez
et al.
2011 [95]

Resistancetrained college
males (n = 8)

−26 g Pre-workout
with unknown
amount of caffeine
(ingredients listed in
column 5)
-Placebo

*↑ # of Bench-Press and Squat Repetitions at 80% 1RM by 11.8%
*↑ Average Power Output for the
Workout

Astorino
et al.
2011 [96]

Collegiate
female soccer
players (n = 15)

-255 mL energy drink
with 1.3 mg/kg
caffeine + 1 g taurine
-Placebo

⬌ Sprint-based Exercise Performance -1 g taurine

Campbell
et al.
2016 [97]

College men
(n = 8) and
women (n = 11)

-37 mL Energy shot
with 2.4 mg/kg
caffeine

⬌ Vertical Jump
⬌ YMCA Bench-Press
NS↑ Curl-up Endurance

-2.05 g taurine, caffeine, and
gluconolactone, 7.9 g L-leucine, Lisoleucine, L-valine, L-arginine and
L-glutamine, 5 g of di-creatine citrate, and 2.5 g of βalanine
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Table 8 Energy drinks and pre-workout supplements (Continued)
Author

Participants

Protocol

Results

Other supplements

-37 mL Placebo

Anaerobic
Exercise
Performance
for Power

Mood/
Reaction
Time/
Alertness

Eckerson
et al.
2013 [98]

Resistancetrained men
(n = 17)

−500 mL Energy drink ⬌ 1RM Bench-Press Strength
with 160 mg
⬌ Total Volume Lifted
caffeine + 2 g taurine
− 500 mL Energy drink
with 160 mg caffeine
− 500 mL Placebo

Astley
et al.
2018 [99]

Resistancetrained men
(n = 15)

-Energy drink with
2.5 mg/kg caffeine
-Non-caffeinated
version of energy drink

*↑ Knee Extensions in Dominant Leg
*↑ 80% 1RM Bench-Press Reps
*↑ Isometric Grip Strength

Magrini
et al.
2016
[100]

Healthy men
(n = 23) and
women (n = 8)

-4 oz Energy drink
with 158 mg caffeine
-4 oz. Placebo

⬌ Total Push-ups

Forbes
et al.
2007 [93]

Young men
(n = 11) and
women (n = 4)

-Energy drink with 2
mg/kg caffeine
-Non-caffeinated
version of energy drink

⬌ Wingate Peak Power
⬌ Wingate Average Power

Campbell
et al.
2010
[101]

Recreationally
active young
men (n = 9) and
women (n = 6)

-Energy drink with
2.1 mg/kg caffeine
-Non-caffeinated
version of energy drink

⬌ Wingate Peak Power

Hoffman
et al.
2009
[102]

Male strength/
power athletes
(n = 12)

-Energy drink with
1.8 mg/kg caffeine
-Non-caffeinated
version of energy drink

⬌ Wingate Power Performance

Alford
et al.
2001 [85]

Young adults
(n = 36)

−250 mL Energy drink *↑ Maximum Speed on Cycle
with 80 mg caffeine
Ergometer
and 26 g CHO
-Carbonated placebo
-No drink

Campbell
et al.
2016 [97]

College men
(n = 8) and
women (n = 11)

-37 mL Energy shot
with 2.4 mg/kg
caffeine
-37 mL Placebo

⬌ Repeated Sprint Speed

Alford
et al.
2001 [85]

Young adults
(n = 36)

-250 mL Energy drink
with 80 mg caffeine
and 26 g CHO
-Carbonated placebo
-No drink

*↑ Choice Reaction Time
*↑ Concentration
*↑ Memory

-26 g CHO

Walsh
et al.
2010 [87]

Recreationally
active men (n =
9) and women
(n = 6)

-26 g Pre-workout
with unknown
amount of caffeine
(ingredients listed in
column 5)
-Placebo

*↑ Focus and Energy in 1st 10 min of
Exercise
⬌ Energy, Fatigue, and Focus
Immediately Post-exercise

-2.05 g taurine, caffeine, and
gluconolactone, 7.9 g L-leucine, Lisoleucine, L-valine, L-arginine and
L-glutamine, 5 g of di-creatine citrate, and 2.5 g of βalanine

Hoffman
et al.
2009
[102]

Male strength/
power athletes
(n = 12)

-Energy drink with
1.8 mg/kg caffeine
-Non-caffeinated
version of energy drink

*↓ Reaction Time
*↑ Feelings of Energy and Focus
NS↑ Alertness

Seidl et al. Male (n = 4) and -Energy drink with
2000
female (n = 6)
160 mg caffeine
graduate
-Placebo
[103]
students
Scholey
et al.
2004
[104]

Healthy
volunteers (n =
20)

-250 ml Energy drink
with 75 mg caffeine
-Non-caffeinated
version of energy drink
-Placebo

−2 g Taurine

-26 g CHO

*↓ Reaction Time at Night
⬌ Vitality Scores at Night
[[when compared to the Placebo
Group who saw a significant decline
in vitality and response time]]

2.0 g taurine, 1.2 g
glucuronolactone, 54 g
carbohydrate, 40 mg niacin, 10 mg
pantothenic acid, 10 mg vitamin
B6, and 10 microg vitamin B12

*↑ Secondary Memory
*↑ Speed of Attention

−37.5 g glucose, ginseng, and
Ginkgo biloba
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Table 8 Energy drinks and pre-workout supplements (Continued)
Author

Protocol

Results

Other supplements

Smit et al. Healthy
2004
volunteers (n =
[105]
271)

Participants

-Caffeine + CHO +
Carbonation
-Placebo with
carbonation
-Placebo without
carbonation

⬌ Mood and Performance (during
fatiguing and cognitively demanding
tasks)

-CHO

Rao et al.
2005
[106]

Healthy
volunteers (n =
40)

-Caffeine + CHO
-Placebo

*↑ Event Related Potentials in ECGs
*↑ Behavioral Performance in
Accuracy and Speed of Performance

-CHO

Howard
et al.
2010
[107]

College
students (n =
80)

-Energy drink with 1.8
ml/kg caffeine**
-Energy drink with
3.6 ml/kg caffeine
-Energy drink with
5.4 ml/kg caffeine
-Non-caffeinated
version of energy drink
-No drink

Compared with the placebo and no
drink conditions, the energy drink
doses decreased reaction times on
the behavioral control task, increased
subjective ratings of stimulation and
decreased ratings of mental fatigue.
Greatest improvements in reaction
times and subjective measures were
observed with the lowest dose (1/8
mg/kg).

Taurine, sucrose and glucose, Bgroup vitamins

Wesnes
et al.
2016
[108]

Young
volunteers (n =
24)

-250 mL Energy drink
with 80 mg caffeine +
27 g glucose
-250 mL Energy drink
with 80 mg caffeine
-250 mL Placebo

*↑ Working and Episodic Memory

-27 g Glucose

Outcomes are bold group specific; * = significant difference, ⬌ = no change, ↑ = improved performance, ↓ = decrease, TT = time trial, RPA = rating of perceived
exertion, NS = non-significant improvement, mg/kg = milligram per kilogram, g = grams, CHO = carbohydrate, min = minutes, VO2 = aerobic capacity, m = meters,
ml = milliliters, RPE = rating of perceived exertion

that the additional taurine to caffeine containing energy
drinks or pre-workout supplements, as well as the
addition of other ergogenic supplements such as betaalanine, B-vitamins, and citrulline, may potentiate the effectiveness of caffeine containing beverages on athletic
performance endeavors [419]. However, other suggest
that the ergogenic benefits of caffeine containing energy
drinks is likely attributed to the caffeine content of the
beverage [420]. For a thorough review of energy drinks,
consider Campbell et al. [419]. Table 8 provides a review
of research related to energy drinks and pre-workout
supplements.
Summary

Caffeine in its many forms is a ubiquitous substance frequently used in military, athletic and fitness populations
which acutely enhance many aspects of exercise performance in most, but not all studies.
Supplementation with caffeine has been shown to
acutely enhance many aspects of exercise, including prolonged aerobic-type activities and brief duration, highintensity exercise. Caffeine is ergogenic when consumed
in doses of 3–6 mg/kg body mass. The most commonly
used timing of caffeine supplementation is 60 min preexercise. The optimal timing of caffeine ingestion likely
depends on the source of caffeine. Caffeine’s effects seem
to be similar in both trained and untrained individuals.
Studies that present individual participant data

commonly report substantial variation in caffeine ingestion responses. Inter-individual differences may be associated with habitual caffeine intake, genetic variations,
and supplementation protocols in a given study. Caffeine
may be ergogenic for cognitive function, including attention and vigilance. Caffeine may improve cognitive and
physical performance in some individuals under conditions of sleep deprivation. Caffeine at the recommended
doses does not appear significantly influence hydration,
and the use of caffeine in conjunction with exercise in
the heat and at altitude is also well supported. Alternative sources of caffeine, such as caffeinated chewing
gum, mouth rinses, and energy gels, have also been
shown to improve performance. Energy drinks and
pre-workouts containing caffeine have been demonstrated to enhance both anaerobic and aerobic performance. Individuals should also be aware of the
side-effects associated with caffeine ingestion, such as
sleep disturbance and anxiety, which are often linearly
dose-dependent.
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